Gene Symbol | Gene ID | Gene Info |
---|---|---|
Klf8
|
ENSMUSG00000041649.7 | Kruppel-like factor 8 |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chrX_153239745_153240209 | Klf8 | 2229 | 0.315042 | 0.27 | 3.9e-02 | Click! |
chrX_153359371_153360659 | Klf8 | 402 | 0.878746 | -0.26 | 4.7e-02 | Click! |
chrX_153285184_153285335 | Klf8 | 47511 | 0.134820 | -0.24 | 6.5e-02 | Click! |
chrX_153237409_153238458 | Klf8 | 185 | 0.950491 | -0.20 | 1.2e-01 | Click! |
chrX_153361731_153361979 | Klf8 | 2242 | 0.348925 | 0.13 | 3.2e-01 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr11_101740028_101740377 | 6.24 |
Dhx8 |
DEAH (Asp-Glu-Ala-His) box polypeptide 8 |
7161 |
0.15 |
chr1_19215607_19218714 | 5.82 |
Tfap2b |
transcription factor AP-2 beta |
3281 |
0.25 |
chr8_70119024_70120981 | 4.46 |
Ncan |
neurocan |
871 |
0.35 |
chr14_28508967_28511864 | 4.40 |
Wnt5a |
wingless-type MMTV integration site family, member 5A |
203 |
0.89 |
chr11_80479429_80480178 | 3.76 |
Cdk5r1 |
cyclin-dependent kinase 5, regulatory subunit 1 (p35) |
2747 |
0.26 |
chr10_3863416_3864702 | 3.54 |
Gm16149 |
predicted gene 16149 |
5548 |
0.21 |
chr12_102555272_102555761 | 3.33 |
Chga |
chromogranin A |
530 |
0.74 |
chrX_170674573_170675954 | 3.28 |
Asmt |
acetylserotonin O-methyltransferase |
2619 |
0.41 |
chr9_91378153_91379783 | 3.21 |
Zic4 |
zinc finger protein of the cerebellum 4 |
326 |
0.81 |
chr19_45230983_45235468 | 3.18 |
Lbx1 |
ladybird homeobox 1 |
2587 |
0.27 |
chr2_74725879_74728683 | 2.99 |
Hoxd4 |
homeobox D4 |
207 |
0.67 |
chr7_137309191_137310700 | 2.98 |
Ebf3 |
early B cell factor 3 |
3971 |
0.23 |
chr2_74737192_74739622 | 2.95 |
Hoxd3 |
homeobox D3 |
1212 |
0.2 |
chr9_58197310_58202560 | 2.88 |
Islr2 |
immunoglobulin superfamily containing leucine-rich repeat 2 |
637 |
0.54 |
chr15_102965066_102967702 | 2.88 |
Hoxc10 |
homeobox C10 |
412 |
0.6 |
chr7_24533103_24534565 | 2.81 |
Irgq |
immunity-related GTPase family, Q |
3145 |
0.1 |
chr5_116590520_116593206 | 2.74 |
Srrm4 |
serine/arginine repetitive matrix 4 |
46 |
0.98 |
chr2_25577192_25580600 | 2.64 |
Ajm1 |
apical junction component 1 |
1001 |
0.25 |
chr15_99527112_99528245 | 2.58 |
Faim2 |
Fas apoptotic inhibitory molecule 2 |
3 |
0.96 |
chr12_52700044_52701597 | 2.51 |
Akap6 |
A kinase (PRKA) anchor protein 6 |
1437 |
0.46 |
chr5_75148315_75152589 | 2.49 |
Pdgfra |
platelet derived growth factor receptor, alpha polypeptide |
1840 |
0.2 |
chr10_81229656_81230911 | 2.49 |
Atcay |
ataxia, cerebellar, Cayman type |
502 |
0.53 |
chr4_139832357_139834219 | 2.47 |
Pax7 |
paired box 7 |
240 |
0.94 |
chr3_8509825_8511666 | 2.45 |
Stmn2 |
stathmin-like 2 |
1159 |
0.54 |
chr1_115684558_115685809 | 2.45 |
Cntnap5a |
contactin associated protein-like 5A |
427 |
0.58 |
chr7_121391567_121393161 | 2.41 |
Hs3st2 |
heparan sulfate (glucosamine) 3-O-sulfotransferase 2 |
74 |
0.93 |
chr17_15544030_15544829 | 2.37 |
Gm18564 |
predicted gene, 18564 |
3387 |
0.13 |
chr7_128252002_128253012 | 2.34 |
Tgfb1i1 |
transforming growth factor beta 1 induced transcript 1 |
4331 |
0.09 |
chr5_147304305_147307985 | 2.34 |
Cdx2 |
caudal type homeobox 2 |
1125 |
0.33 |
chrX_7638310_7639997 | 2.34 |
Syp |
synaptophysin |
152 |
0.88 |
chr11_96329848_96331152 | 2.31 |
Hoxb3 |
homeobox B3 |
2438 |
0.11 |
chr7_79501250_79502506 | 2.29 |
Mir9-3hg |
Mir9-3 host gene |
1757 |
0.18 |
chr14_21984849_21986226 | 2.29 |
Zfp503 |
zinc finger protein 503 |
4064 |
0.17 |
chrX_105390628_105392456 | 2.27 |
5330434G04Rik |
RIKEN cDNA 5330434G04 gene |
212 |
0.93 |
chr4_110285468_110287125 | 2.26 |
Elavl4 |
ELAV like RNA binding protein 4 |
320 |
0.94 |
chr11_96292706_96294113 | 2.26 |
Hoxb6 |
homeobox B6 |
933 |
0.29 |
chr8_108716860_108718878 | 2.26 |
Zfhx3 |
zinc finger homeobox 3 |
3225 |
0.3 |
chr2_116056837_116059755 | 2.23 |
Meis2 |
Meis homeobox 2 |
546 |
0.75 |
chr14_122478089_122479067 | 2.23 |
Zic2 |
zinc finger protein of the cerebellum 2 |
478 |
0.68 |
chr2_157914223_157915670 | 2.23 |
Vstm2l |
V-set and transmembrane domain containing 2-like |
293 |
0.91 |
chr2_26646949_26647190 | 2.22 |
Snhg7os |
small nucleolar RNA host gene 7, opposite strand |
3180 |
0.12 |
chr2_152081612_152083149 | 2.21 |
Scrt2 |
scratch family zinc finger 2 |
851 |
0.52 |
chr6_112945034_112945954 | 2.20 |
Srgap3 |
SLIT-ROBO Rho GTPase activating protein 3 |
1260 |
0.31 |
chr11_118908287_118909561 | 2.20 |
Rbfox3 |
RNA binding protein, fox-1 homolog (C. elegans) 3 |
626 |
0.73 |
chrX_7919510_7921219 | 2.19 |
Pcsk1n |
proprotein convertase subtilisin/kexin type 1 inhibitor |
542 |
0.52 |
chr18_43686487_43688415 | 2.18 |
Jakmip2 |
janus kinase and microtubule interacting protein 2 |
174 |
0.96 |
chr10_87500739_87501897 | 2.17 |
Gm48120 |
predicted gene, 48120 |
6544 |
0.19 |
chr1_78193153_78194695 | 2.17 |
Pax3 |
paired box 3 |
2914 |
0.3 |
chr3_34648572_34651394 | 2.14 |
Sox2 |
SRY (sex determining region Y)-box 2 |
422 |
0.73 |
chr16_81202167_81203211 | 2.12 |
Ncam2 |
neural cell adhesion molecule 2 |
1932 |
0.44 |
chr15_76519928_76521866 | 2.12 |
Scrt1 |
scratch family zinc finger 1 |
1005 |
0.28 |
chr18_64265051_64265782 | 2.12 |
St8sia3 |
ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 3 |
570 |
0.71 |
chr8_105469813_105470589 | 2.11 |
Tppp3 |
tubulin polymerization-promoting protein family member 3 |
791 |
0.45 |
chr7_92234907_92236280 | 2.10 |
Dlg2 |
discs large MAGUK scaffold protein 2 |
466 |
0.88 |
chr19_44758783_44762005 | 2.10 |
Pax2 |
paired box 2 |
479 |
0.75 |
chr6_136172206_136173574 | 2.08 |
Gm26653 |
predicted gene, 26653 |
171 |
0.59 |
chr12_110187430_110189676 | 2.08 |
Gm34785 |
predicted gene, 34785 |
492 |
0.73 |
chr2_105680581_105683424 | 2.07 |
Pax6 |
paired box 6 |
290 |
0.89 |
chr1_72826047_72827238 | 2.04 |
Igfbp2 |
insulin-like growth factor binding protein 2 |
1320 |
0.5 |
chr8_122226812_122226963 | 2.04 |
Zfp469 |
zinc finger protein 469 |
31733 |
0.15 |
chr2_9882196_9886301 | 2.00 |
9230102O04Rik |
RIKEN cDNA 9230102O04 gene |
255 |
0.84 |
chr6_52208128_52210195 | 1.99 |
Hoxa6 |
homeobox A6 |
439 |
0.52 |
chr11_55606583_55606948 | 1.99 |
Glra1 |
glycine receptor, alpha 1 subunit |
968 |
0.59 |
chr15_103009345_103011570 | 1.98 |
Hoxc6 |
homeobox C6 |
884 |
0.35 |
chr14_104465474_104466650 | 1.98 |
Pou4f1 |
POU domain, class 4, transcription factor 1 |
697 |
0.67 |
chr6_91409540_91411888 | 1.98 |
Wnt7a |
wingless-type MMTV integration site family, member 7A |
649 |
0.42 |
chr5_120706498_120706989 | 1.98 |
Dtx1 |
deltex 1, E3 ubiquitin ligase |
854 |
0.44 |
chr1_92849002_92850443 | 1.97 |
Mir149 |
microRNA 149 |
656 |
0.43 |
chr10_29143400_29144848 | 1.97 |
Soga3 |
SOGA family member 3 |
65 |
0.5 |
chr2_172549301_172551909 | 1.96 |
Tfap2c |
transcription factor AP-2, gamma |
48 |
0.98 |
chr8_123413418_123414506 | 1.95 |
Tubb3 |
tubulin, beta 3 class III |
2372 |
0.11 |
chr6_52309839_52312950 | 1.94 |
Evx1 |
even-skipped homeobox 1 |
2104 |
0.14 |
chr8_92364963_92367136 | 1.93 |
Irx5 |
Iroquois homeobox 5 |
8300 |
0.18 |
chr17_93198991_93201483 | 1.93 |
Adcyap1 |
adenylate cyclase activating polypeptide 1 |
302 |
0.89 |
chr15_85576096_85578271 | 1.91 |
Wnt7b |
wingless-type MMTV integration site family, member 7B |
887 |
0.54 |
chr7_131966504_131967699 | 1.91 |
Gpr26 |
G protein-coupled receptor 26 |
641 |
0.75 |
chr6_114130915_114132167 | 1.90 |
Slc6a11 |
solute carrier family 6 (neurotransmitter transporter, GABA), member 11 |
122 |
0.97 |
chr1_42697532_42698715 | 1.89 |
Pou3f3 |
POU domain, class 3, transcription factor 3 |
2355 |
0.2 |
chr7_25153391_25155013 | 1.89 |
D930028M14Rik |
RIKEN cDNA D930028M14 gene |
867 |
0.45 |
chr5_32153164_32153923 | 1.88 |
Fosl2 |
fos-like antigen 2 |
7022 |
0.15 |
chr12_117153278_117156362 | 1.88 |
Gm10421 |
predicted gene 10421 |
3169 |
0.37 |
chr2_152080491_152081480 | 1.88 |
Scrt2 |
scratch family zinc finger 2 |
544 |
0.7 |
chr2_74713881_74716227 | 1.87 |
Hoxd3os1 |
homeobox D3, opposite strand 1 |
942 |
0.23 |
chr9_22050521_22051976 | 1.86 |
Elavl3 |
ELAV like RNA binding protein 3 |
762 |
0.41 |
chr3_55782570_55784448 | 1.86 |
Nbea |
neurobeachin |
19 |
0.96 |
chr1_173366699_173367980 | 1.85 |
Cadm3 |
cell adhesion molecule 3 |
294 |
0.89 |
chr3_94478073_94479450 | 1.85 |
Celf3 |
CUGBP, Elav-like family member 3 |
70 |
0.92 |
chr11_55607331_55608633 | 1.85 |
Glra1 |
glycine receptor, alpha 1 subunit |
161 |
0.96 |
chr18_60925301_60926809 | 1.85 |
Camk2a |
calcium/calmodulin-dependent protein kinase II alpha |
330 |
0.84 |
chr14_122459815_122460898 | 1.82 |
Zic5 |
zinc finger protein of the cerebellum 5 |
335 |
0.81 |
chr10_127528295_127529341 | 1.81 |
Nxph4 |
neurexophilin 4 |
5741 |
0.1 |
chr2_172040251_172043672 | 1.80 |
Cbln4 |
cerebellin 4 precursor protein |
1505 |
0.35 |
chr8_94994139_94995207 | 1.80 |
Adgrg1 |
adhesion G protein-coupled receptor G1 |
77 |
0.95 |
chr10_80300884_80302968 | 1.79 |
Apc2 |
APC regulator of WNT signaling pathway 2 |
106 |
0.9 |
chr8_125897868_125898882 | 1.78 |
Pcnx2 |
pecanex homolog 2 |
58 |
0.88 |
chr4_125490136_125491914 | 1.78 |
Grik3 |
glutamate receptor, ionotropic, kainate 3 |
325 |
0.89 |
chr7_19175632_19177533 | 1.78 |
Eml2 |
echinoderm microtubule associated protein like 2 |
161 |
0.88 |
chr2_105675959_105678109 | 1.77 |
Pax6 |
paired box 6 |
905 |
0.54 |
chr14_52310870_52313267 | 1.75 |
Sall2 |
spalt like transcription factor 2 |
4255 |
0.1 |
chr14_64592253_64592626 | 1.75 |
Mir3078 |
microRNA 3078 |
1254 |
0.34 |
chr7_44336079_44337576 | 1.74 |
Shank1 |
SH3 and multiple ankyrin repeat domains 1 |
811 |
0.34 |
chr19_8838893_8839483 | 1.74 |
Gng3 |
guanine nucleotide binding protein (G protein), gamma 3 |
6 |
0.61 |
chrX_111894411_111895700 | 1.74 |
Gm45194 |
predicted gene 45194 |
3479 |
0.27 |
chr3_146101204_146101488 | 1.73 |
Wdr63 |
WD repeat domain 63 |
6784 |
0.16 |
chr9_69758963_69761490 | 1.73 |
Foxb1 |
forkhead box B1 |
714 |
0.5 |
chr15_74516560_74519631 | 1.72 |
Adgrb1 |
adhesion G protein-coupled receptor B1 |
1264 |
0.47 |
chr3_154329308_154331090 | 1.72 |
Lhx8 |
LIM homeobox protein 8 |
140 |
0.88 |
chr16_9994378_9995594 | 1.68 |
Grin2a |
glutamate receptor, ionotropic, NMDA2A (epsilon 1) |
63 |
0.98 |
chr10_79867078_79867672 | 1.67 |
Plppr3 |
phospholipid phosphatase related 3 |
94 |
0.88 |
chr8_124794588_124794799 | 1.66 |
Trim67 |
tripartite motif-containing 67 |
1601 |
0.26 |
chr7_140080531_140082545 | 1.65 |
Caly |
calcyon neuron-specific vesicular protein |
689 |
0.48 |
chr2_25264308_25268001 | 1.64 |
Tprn |
taperin |
1410 |
0.14 |
chr2_74734325_74737080 | 1.63 |
Hoxd3 |
homeobox D3 |
813 |
0.31 |
chr7_4121960_4122900 | 1.63 |
Ttyh1 |
tweety family member 1 |
281 |
0.78 |
chr14_66910135_66911764 | 1.63 |
Pnma2 |
paraneoplastic antigen MA2 |
221 |
0.91 |
chr6_94695739_94697689 | 1.62 |
Lrig1 |
leucine-rich repeats and immunoglobulin-like domains 1 |
3423 |
0.29 |
chr1_146494200_146495557 | 1.62 |
Gm29514 |
predicted gene 29514 |
73 |
0.56 |
chr4_150651111_150652374 | 1.62 |
Slc45a1 |
solute carrier family 45, member 1 |
355 |
0.88 |
chr7_126702563_126704731 | 1.62 |
Coro1a |
coronin, actin binding protein 1A |
473 |
0.55 |
chr7_78882466_78883900 | 1.61 |
Mir7-2 |
microRNA 7-2 |
5094 |
0.13 |
chr1_177446374_177448525 | 1.60 |
Zbtb18 |
zinc finger and BTB domain containing 18 |
1628 |
0.31 |
chr11_84526864_84527823 | 1.60 |
Lhx1os |
LIM homeobox 1, opposite strand |
1659 |
0.31 |
chr6_55676662_55677830 | 1.60 |
Neurod6 |
neurogenic differentiation 6 |
4017 |
0.26 |
chr2_158614356_158617139 | 1.60 |
Gm14205 |
predicted gene 14205 |
3927 |
0.13 |
chrX_143930842_143933141 | 1.60 |
Dcx |
doublecortin |
1059 |
0.64 |
chr7_64501626_64502920 | 1.59 |
Apba2 |
amyloid beta (A4) precursor protein-binding, family A, member 2 |
135 |
0.96 |
chr8_41054476_41055299 | 1.59 |
Mtus1 |
mitochondrial tumor suppressor 1 |
93 |
0.95 |
chr7_108950187_108951385 | 1.58 |
Tub |
tubby bipartite transcription factor |
129 |
0.94 |
chr2_180889143_180889758 | 1.58 |
Gm14342 |
predicted gene 14342 |
210 |
0.87 |
chr6_17681823_17681974 | 1.58 |
St7 |
suppression of tumorigenicity 7 |
11035 |
0.14 |
chr2_74739700_74741193 | 1.57 |
Hoxd3 |
homeobox D3 |
827 |
0.31 |
chr2_31638722_31641540 | 1.57 |
Prdm12 |
PR domain containing 12 |
94 |
0.84 |
chr7_79507205_79507895 | 1.57 |
Mir9-3 |
microRNA 9-3 |
2286 |
0.14 |
chr7_51626624_51628140 | 1.57 |
Slc17a6 |
solute carrier family 17 (sodium-dependent inorganic phosphate cotransporter), member 6 |
2098 |
0.31 |
chr12_108271341_108272893 | 1.56 |
Ccdc85c |
coiled-coil domain containing 85C |
3016 |
0.24 |
chr15_85580567_85581814 | 1.55 |
AU022754 |
expressed sequence AU022754 |
48 |
0.86 |
chr7_49634786_49637154 | 1.54 |
Dbx1 |
developing brain homeobox 1 |
879 |
0.68 |
chr7_4920681_4922210 | 1.54 |
Nat14 |
N-acetyltransferase 14 |
583 |
0.48 |
chr4_136834855_136835984 | 1.53 |
Ephb2 |
Eph receptor B2 |
424 |
0.84 |
chr2_113828248_113829427 | 1.52 |
Scg5 |
secretogranin V |
75 |
0.97 |
chr17_46087425_46087576 | 1.52 |
Gm36200 |
predicted gene, 36200 |
3234 |
0.16 |
chr16_96280491_96281572 | 1.52 |
B3galt5 |
UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase, polypeptide 5 |
233 |
0.93 |
chrX_57916667_57918033 | 1.52 |
Gm25023 |
predicted gene, 25023 |
72123 |
0.11 |
chr1_163308490_163310681 | 1.51 |
Gm37644 |
predicted gene, 37644 |
518 |
0.77 |
chr11_84528176_84528860 | 1.50 |
Lhx1os |
LIM homeobox 1, opposite strand |
2834 |
0.24 |
chr12_72233267_72233815 | 1.49 |
Rtn1 |
reticulon 1 |
2198 |
0.35 |
chr11_96331807_96334248 | 1.49 |
Hoxb3 |
homeobox B3 |
4965 |
0.08 |
chr7_74012361_74013617 | 1.49 |
St8sia2 |
ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 2 |
685 |
0.71 |
chr7_25180336_25182324 | 1.49 |
Pou2f2 |
POU domain, class 2, transcription factor 2 |
1604 |
0.22 |
chr2_33641457_33645822 | 1.48 |
C130021I20Rik |
Riken cDNA C130021I20 gene |
2308 |
0.22 |
chr9_54764594_54766122 | 1.48 |
Crabp1 |
cellular retinoic acid binding protein I |
610 |
0.69 |
chr5_137553079_137554278 | 1.48 |
Actl6b |
actin-like 6B |
121 |
0.89 |
chr13_63557270_63560459 | 1.47 |
Ptch1 |
patched 1 |
4951 |
0.16 |
chr5_37241461_37244349 | 1.47 |
Crmp1 |
collapsin response mediator protein 1 |
171 |
0.95 |
chr9_91363064_91363717 | 1.47 |
Zic1 |
zinc finger protein of the cerebellum 1 |
336 |
0.72 |
chr11_96343236_96346574 | 1.46 |
Hoxb3 |
homeobox B3 |
1136 |
0.24 |
chr9_58195999_58197293 | 1.46 |
Islr2 |
immunoglobulin superfamily containing leucine-rich repeat 2 |
3926 |
0.12 |
chr19_22138603_22139842 | 1.46 |
Trpm3 |
transient receptor potential cation channel, subfamily M, member 3 |
105 |
0.98 |
chr19_38096667_38098081 | 1.45 |
Ffar4 |
free fatty acid receptor 4 |
303 |
0.86 |
chr10_116017652_116019652 | 1.44 |
Ptprr |
protein tyrosine phosphatase, receptor type, R |
365 |
0.92 |
chr7_126952524_126952951 | 1.44 |
Sez6l2 |
seizure related 6 homolog like 2 |
1130 |
0.2 |
chr4_104367071_104368427 | 1.44 |
Dab1 |
disabled 1 |
159 |
0.98 |
chr5_111421306_111422790 | 1.44 |
Gm43119 |
predicted gene 43119 |
1541 |
0.35 |
chr2_18042311_18043883 | 1.44 |
Skida1 |
SKI/DACH domain containing 1 |
1475 |
0.25 |
chr7_99270744_99271357 | 1.43 |
Map6 |
microtubule-associated protein 6 |
1918 |
0.23 |
chr8_124795343_124796098 | 1.42 |
Trim67 |
tripartite motif-containing 67 |
2628 |
0.18 |
chr10_80028320_80028471 | 1.41 |
Arhgap45 |
Rho GTPase activating protein 45 |
6652 |
0.08 |
chr13_54789087_54790430 | 1.41 |
Tspan17 |
tetraspanin 17 |
113 |
0.94 |
chr4_154635108_154637998 | 1.41 |
Prdm16 |
PR domain containing 16 |
244 |
0.83 |
chr7_144238658_144240098 | 1.41 |
Shank2 |
SH3 and multiple ankyrin repeat domains 2 |
653 |
0.8 |
chr2_10372882_10374693 | 1.40 |
Gm13261 |
predicted gene 13261 |
254 |
0.68 |
chr5_131535782_131536209 | 1.40 |
Auts2 |
autism susceptibility candidate 2 |
1598 |
0.38 |
chr2_109693096_109694906 | 1.40 |
Bdnf |
brain derived neurotrophic factor |
408 |
0.85 |
chr7_137311015_137311991 | 1.40 |
Ebf3 |
early B cell factor 3 |
2413 |
0.29 |
chr6_114282516_114283979 | 1.40 |
Slc6a1 |
solute carrier family 6 (neurotransmitter transporter, GABA), member 1 |
457 |
0.87 |
chr1_172056022_172057415 | 1.39 |
Nhlh1 |
nescient helix loop helix 1 |
855 |
0.45 |
chr10_80298461_80300404 | 1.39 |
Apc2 |
APC regulator of WNT signaling pathway 2 |
341 |
0.69 |
chr11_54057587_54057738 | 1.39 |
Pdlim4 |
PDZ and LIM domain 4 |
6906 |
0.16 |
chr1_74855603_74856370 | 1.38 |
Cdk5r2 |
cyclin-dependent kinase 5, regulatory subunit 2 (p39) |
1052 |
0.36 |
chr14_21982606_21983939 | 1.38 |
Zfp503 |
zinc finger protein 503 |
6329 |
0.15 |
chr5_30712882_30713845 | 1.38 |
Dpysl5 |
dihydropyrimidinase-like 5 |
1462 |
0.33 |
chr19_6499251_6500132 | 1.38 |
Nrxn2 |
neurexin II |
1856 |
0.23 |
chr11_98327227_98329144 | 1.38 |
Neurod2 |
neurogenic differentiation 2 |
1463 |
0.23 |
chr10_80383278_80383957 | 1.38 |
Gm22721 |
predicted gene, 22721 |
1315 |
0.17 |
chr10_80154971_80156076 | 1.37 |
Midn |
midnolin |
4285 |
0.09 |
chr8_17532221_17533470 | 1.37 |
Csmd1 |
CUB and Sushi multiple domains 1 |
2436 |
0.46 |
chr6_84591507_84592679 | 1.37 |
Cyp26b1 |
cytochrome P450, family 26, subfamily b, polypeptide 1 |
1653 |
0.47 |
chr6_52231944_52233433 | 1.37 |
Hoxa10 |
homeobox A10 |
636 |
0.35 |
chr19_5686209_5687218 | 1.37 |
Pcnx3 |
pecanex homolog 3 |
1436 |
0.16 |
chrX_140061291_140062848 | 1.37 |
Nup62cl |
nucleoporin 62 C-terminal like |
224 |
0.85 |
chr19_6499015_6499234 | 1.36 |
Nrxn2 |
neurexin II |
1289 |
0.32 |
chr8_124792307_124794543 | 1.36 |
Trim67 |
tripartite motif-containing 67 |
333 |
0.82 |
chr2_143545470_143546713 | 1.36 |
Pcsk2 |
proprotein convertase subtilisin/kexin type 2 |
65 |
0.56 |
chr10_11081408_11082323 | 1.36 |
Grm1 |
glutamate receptor, metabotropic 1 |
385 |
0.89 |
chr16_75446825_75447522 | 1.36 |
Gm49678 |
predicted gene, 49678 |
120 |
0.98 |
chr2_180890379_180892235 | 1.35 |
Gm14342 |
predicted gene 14342 |
1647 |
0.19 |
chr2_121357946_121359451 | 1.35 |
Ckmt1 |
creatine kinase, mitochondrial 1, ubiquitous |
32 |
0.95 |
chr9_106456260_106457377 | 1.35 |
Pcbp4 |
poly(rC) binding protein 4 |
721 |
0.42 |
chr14_66344363_66345813 | 1.35 |
Stmn4 |
stathmin-like 4 |
707 |
0.65 |
chr18_43390784_43391261 | 1.35 |
Dpysl3 |
dihydropyrimidinase-like 3 |
2355 |
0.34 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.3 | 7.0 | GO:0021538 | epithalamus development(GO:0021538) habenula development(GO:0021986) |
1.9 | 5.8 | GO:0061642 | chemoattraction of axon(GO:0061642) |
1.9 | 7.7 | GO:0061205 | paramesonephric duct development(GO:0061205) |
1.8 | 7.2 | GO:0021615 | glossopharyngeal nerve morphogenesis(GO:0021615) |
1.2 | 3.5 | GO:0021586 | pons maturation(GO:0021586) |
1.1 | 3.4 | GO:0072137 | condensed mesenchymal cell proliferation(GO:0072137) |
1.1 | 14.5 | GO:0071625 | vocalization behavior(GO:0071625) |
1.1 | 3.2 | GO:0021570 | rhombomere 4 development(GO:0021570) |
1.0 | 2.0 | GO:0097477 | lateral motor column neuron migration(GO:0097477) |
1.0 | 1.0 | GO:1900452 | regulation of long term synaptic depression(GO:1900452) |
1.0 | 2.0 | GO:2000019 | negative regulation of male gonad development(GO:2000019) |
1.0 | 3.9 | GO:0007412 | axon target recognition(GO:0007412) |
1.0 | 2.9 | GO:0071205 | protein localization to juxtaparanode region of axon(GO:0071205) |
0.9 | 1.9 | GO:0021912 | regulation of transcription from RNA polymerase II promoter involved in spinal cord motor neuron fate specification(GO:0021912) |
0.9 | 1.9 | GO:0048880 | sensory system development(GO:0048880) |
0.9 | 2.8 | GO:1900738 | positive regulation of phospholipase C-activating G-protein coupled receptor signaling pathway(GO:1900738) |
0.9 | 0.9 | GO:0097118 | neuroligin clustering involved in postsynaptic membrane assembly(GO:0097118) |
0.9 | 11.7 | GO:0021527 | spinal cord association neuron differentiation(GO:0021527) |
0.9 | 0.9 | GO:0015744 | succinate transport(GO:0015744) |
0.8 | 0.8 | GO:0072309 | mesenchymal stem cell maintenance involved in metanephric nephron morphogenesis(GO:0072309) |
0.8 | 2.5 | GO:0002930 | trabecular meshwork development(GO:0002930) |
0.8 | 5.9 | GO:0097119 | postsynaptic density protein 95 clustering(GO:0097119) |
0.8 | 1.7 | GO:0072069 | distal convoluted tubule development(GO:0072025) DCT cell differentiation(GO:0072069) metanephric distal convoluted tubule development(GO:0072221) metanephric distal tubule development(GO:0072235) metanephric DCT cell differentiation(GO:0072240) |
0.8 | 2.5 | GO:0071314 | cellular response to cocaine(GO:0071314) |
0.8 | 2.5 | GO:0002877 | regulation of acute inflammatory response to non-antigenic stimulus(GO:0002877) |
0.8 | 3.3 | GO:0034653 | diterpenoid catabolic process(GO:0016103) retinoic acid catabolic process(GO:0034653) |
0.8 | 2.4 | GO:0008292 | acetylcholine biosynthetic process(GO:0008292) acetate ester biosynthetic process(GO:1900620) |
0.8 | 3.0 | GO:0033563 | dorsal/ventral axon guidance(GO:0033563) |
0.8 | 0.8 | GO:0097168 | mesenchymal stem cell proliferation(GO:0097168) |
0.7 | 2.2 | GO:0009786 | regulation of asymmetric cell division(GO:0009786) |
0.7 | 2.2 | GO:2000474 | regulation of opioid receptor signaling pathway(GO:2000474) |
0.7 | 2.9 | GO:2000382 | positive regulation of mesoderm development(GO:2000382) |
0.7 | 2.9 | GO:0021521 | ventral spinal cord interneuron specification(GO:0021521) cell fate specification involved in pattern specification(GO:0060573) |
0.7 | 2.1 | GO:0099558 | maintenance of synapse structure(GO:0099558) |
0.7 | 1.4 | GO:0048696 | regulation of collateral sprouting in absence of injury(GO:0048696) |
0.7 | 0.7 | GO:0097374 | sensory neuron axon guidance(GO:0097374) |
0.7 | 2.1 | GO:0033058 | directional locomotion(GO:0033058) |
0.7 | 4.1 | GO:0021516 | dorsal spinal cord development(GO:0021516) |
0.7 | 0.7 | GO:0021913 | regulation of transcription from RNA polymerase II promoter involved in ventral spinal cord interneuron specification(GO:0021913) |
0.7 | 2.7 | GO:1900109 | regulation of histone H3-K9 dimethylation(GO:1900109) |
0.7 | 2.6 | GO:0021631 | optic nerve morphogenesis(GO:0021631) |
0.7 | 2.6 | GO:0035279 | mRNA cleavage involved in gene silencing by miRNA(GO:0035279) mRNA cleavage involved in gene silencing(GO:0098795) |
0.7 | 3.9 | GO:0051970 | negative regulation of transmission of nerve impulse(GO:0051970) |
0.7 | 2.6 | GO:0031117 | positive regulation of microtubule depolymerization(GO:0031117) |
0.7 | 2.0 | GO:0045608 | negative regulation of auditory receptor cell differentiation(GO:0045608) |
0.6 | 1.9 | GO:0097503 | sialylation(GO:0097503) |
0.6 | 1.9 | GO:0072017 | distal tubule development(GO:0072017) |
0.6 | 5.1 | GO:0021520 | spinal cord motor neuron cell fate specification(GO:0021520) |
0.6 | 3.1 | GO:0048852 | diencephalon morphogenesis(GO:0048852) |
0.6 | 1.9 | GO:2000211 | regulation of glutamate metabolic process(GO:2000211) |
0.6 | 2.3 | GO:0033564 | anterior/posterior axon guidance(GO:0033564) |
0.6 | 1.7 | GO:0021557 | oculomotor nerve development(GO:0021557) |
0.6 | 7.4 | GO:0060272 | embryonic skeletal joint morphogenesis(GO:0060272) |
0.6 | 1.7 | GO:0061144 | alveolar secondary septum development(GO:0061144) |
0.6 | 1.7 | GO:2001055 | positive regulation of mesenchymal cell apoptotic process(GO:2001055) |
0.6 | 1.7 | GO:0072191 | ureter smooth muscle development(GO:0072191) ureter smooth muscle cell differentiation(GO:0072193) |
0.6 | 1.1 | GO:0021698 | cerebellar cortex structural organization(GO:0021698) |
0.6 | 1.7 | GO:0033693 | neurofilament bundle assembly(GO:0033693) |
0.5 | 2.2 | GO:0048619 | embryonic hindgut morphogenesis(GO:0048619) |
0.5 | 6.4 | GO:0007216 | G-protein coupled glutamate receptor signaling pathway(GO:0007216) |
0.5 | 0.5 | GO:0021550 | medulla oblongata development(GO:0021550) |
0.5 | 1.6 | GO:1904059 | regulation of locomotor rhythm(GO:1904059) |
0.5 | 1.0 | GO:0021555 | midbrain-hindbrain boundary morphogenesis(GO:0021555) |
0.5 | 2.6 | GO:0016198 | axon choice point recognition(GO:0016198) |
0.5 | 2.6 | GO:0000160 | phosphorelay signal transduction system(GO:0000160) |
0.5 | 5.6 | GO:0021978 | telencephalon regionalization(GO:0021978) |
0.5 | 1.0 | GO:0071898 | regulation of estrogen receptor binding(GO:0071898) negative regulation of estrogen receptor binding(GO:0071899) |
0.5 | 1.5 | GO:0036515 | serotonergic neuron axon guidance(GO:0036515) |
0.5 | 5.5 | GO:0035235 | ionotropic glutamate receptor signaling pathway(GO:0035235) |
0.5 | 1.5 | GO:0003357 | noradrenergic neuron differentiation(GO:0003357) |
0.5 | 2.4 | GO:0021979 | hypothalamus cell differentiation(GO:0021979) |
0.5 | 0.5 | GO:0060839 | endothelial cell fate commitment(GO:0060839) |
0.5 | 0.9 | GO:0061743 | motor learning(GO:0061743) |
0.5 | 0.9 | GO:0060066 | oviduct development(GO:0060066) |
0.5 | 0.5 | GO:0021859 | pyramidal neuron differentiation(GO:0021859) |
0.5 | 0.9 | GO:0021523 | somatic motor neuron differentiation(GO:0021523) |
0.5 | 1.4 | GO:0021882 | regulation of transcription from RNA polymerase II promoter involved in forebrain neuron fate commitment(GO:0021882) |
0.5 | 0.9 | GO:0070100 | negative regulation of chemokine-mediated signaling pathway(GO:0070100) |
0.4 | 4.0 | GO:0097120 | receptor localization to synapse(GO:0097120) |
0.4 | 0.4 | GO:2000807 | regulation of synaptic vesicle clustering(GO:2000807) |
0.4 | 0.9 | GO:0060825 | fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation(GO:0060825) regulation of fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation(GO:2000313) |
0.4 | 1.3 | GO:0009449 | gamma-aminobutyric acid biosynthetic process(GO:0009449) |
0.4 | 0.9 | GO:0021797 | forebrain anterior/posterior pattern specification(GO:0021797) |
0.4 | 2.6 | GO:0045631 | regulation of auditory receptor cell differentiation(GO:0045607) regulation of mechanoreceptor differentiation(GO:0045631) regulation of inner ear receptor cell differentiation(GO:2000980) |
0.4 | 2.1 | GO:0050915 | sensory perception of sour taste(GO:0050915) |
0.4 | 1.3 | GO:0002121 | inter-male aggressive behavior(GO:0002121) |
0.4 | 2.5 | GO:0070314 | G1 to G0 transition(GO:0070314) |
0.4 | 0.8 | GO:0031635 | adenylate cyclase-inhibiting opioid receptor signaling pathway(GO:0031635) |
0.4 | 1.6 | GO:2000667 | positive regulation of interleukin-5 secretion(GO:2000664) positive regulation of interleukin-13 secretion(GO:2000667) |
0.4 | 1.2 | GO:0071879 | positive regulation of adrenergic receptor signaling pathway(GO:0071879) |
0.4 | 0.8 | GO:0090027 | negative regulation of monocyte chemotaxis(GO:0090027) |
0.4 | 1.2 | GO:0071895 | odontoblast differentiation(GO:0071895) |
0.4 | 1.2 | GO:0097155 | fasciculation of sensory neuron axon(GO:0097155) |
0.4 | 0.8 | GO:0046532 | regulation of photoreceptor cell differentiation(GO:0046532) |
0.4 | 1.2 | GO:0060221 | retinal rod cell differentiation(GO:0060221) |
0.4 | 1.2 | GO:0001957 | intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
0.4 | 1.6 | GO:1901386 | negative regulation of voltage-gated calcium channel activity(GO:1901386) |
0.4 | 2.4 | GO:0042118 | endothelial cell activation(GO:0042118) |
0.4 | 0.4 | GO:0061004 | pattern specification involved in kidney development(GO:0061004) renal system pattern specification(GO:0072048) |
0.4 | 0.4 | GO:2000302 | positive regulation of synaptic vesicle exocytosis(GO:2000302) |
0.4 | 2.0 | GO:0046958 | nonassociative learning(GO:0046958) |
0.4 | 2.7 | GO:0060600 | dichotomous subdivision of an epithelial terminal unit(GO:0060600) |
0.4 | 1.2 | GO:2000054 | negative regulation of Wnt signaling pathway involved in dorsal/ventral axis specification(GO:2000054) |
0.4 | 1.2 | GO:0042126 | nitrate metabolic process(GO:0042126) |
0.4 | 0.8 | GO:0021773 | striatal medium spiny neuron differentiation(GO:0021773) |
0.4 | 0.8 | GO:0098828 | modulation of inhibitory postsynaptic potential(GO:0098828) |
0.4 | 0.4 | GO:0032097 | positive regulation of response to food(GO:0032097) positive regulation of appetite(GO:0032100) |
0.4 | 1.1 | GO:1902071 | regulation of hypoxia-inducible factor-1alpha signaling pathway(GO:1902071) |
0.4 | 2.2 | GO:0060159 | regulation of dopamine receptor signaling pathway(GO:0060159) |
0.4 | 0.7 | GO:0050975 | sensory perception of touch(GO:0050975) |
0.4 | 1.1 | GO:0051582 | positive regulation of neurotransmitter uptake(GO:0051582) positive regulation of dopamine uptake involved in synaptic transmission(GO:0051586) positive regulation of catecholamine uptake involved in synaptic transmission(GO:0051944) |
0.4 | 2.2 | GO:0048665 | neuron fate specification(GO:0048665) |
0.4 | 0.4 | GO:0003134 | BMP signaling pathway involved in heart induction(GO:0003130) endodermal-mesodermal cell signaling(GO:0003133) endodermal-mesodermal cell signaling involved in heart induction(GO:0003134) cell-cell signaling involved in cell fate commitment(GO:0045168) |
0.4 | 0.7 | GO:2001025 | positive regulation of response to drug(GO:2001025) |
0.4 | 1.8 | GO:0097500 | receptor localization to nonmotile primary cilium(GO:0097500) |
0.4 | 12.0 | GO:0000381 | regulation of alternative mRNA splicing, via spliceosome(GO:0000381) |
0.4 | 1.1 | GO:0006842 | tricarboxylic acid transport(GO:0006842) citrate transport(GO:0015746) |
0.4 | 1.1 | GO:0060023 | soft palate development(GO:0060023) |
0.4 | 2.2 | GO:0014054 | positive regulation of gamma-aminobutyric acid secretion(GO:0014054) |
0.4 | 4.3 | GO:0021681 | cerebellar granular layer development(GO:0021681) |
0.4 | 0.4 | GO:0051462 | cortisol secretion(GO:0043400) regulation of cortisol secretion(GO:0051462) positive regulation of cortisol secretion(GO:0051464) |
0.4 | 1.1 | GO:1901843 | positive regulation of high voltage-gated calcium channel activity(GO:1901843) |
0.4 | 1.8 | GO:0032808 | lacrimal gland development(GO:0032808) |
0.4 | 1.1 | GO:0002118 | aggressive behavior(GO:0002118) |
0.4 | 1.4 | GO:0021637 | trigeminal nerve morphogenesis(GO:0021636) trigeminal nerve structural organization(GO:0021637) |
0.4 | 0.7 | GO:0014053 | negative regulation of gamma-aminobutyric acid secretion(GO:0014053) |
0.4 | 0.7 | GO:0046881 | positive regulation of follicle-stimulating hormone secretion(GO:0046881) |
0.4 | 0.7 | GO:1904948 | midbrain dopaminergic neuron differentiation(GO:1904948) |
0.3 | 1.0 | GO:0032474 | otolith morphogenesis(GO:0032474) |
0.3 | 1.4 | GO:0033326 | cerebrospinal fluid secretion(GO:0033326) |
0.3 | 3.7 | GO:0031290 | retinal ganglion cell axon guidance(GO:0031290) |
0.3 | 4.0 | GO:0048172 | regulation of short-term neuronal synaptic plasticity(GO:0048172) |
0.3 | 0.7 | GO:0097029 | mature conventional dendritic cell differentiation(GO:0097029) |
0.3 | 0.7 | GO:0072257 | metanephric nephron tubule epithelial cell differentiation(GO:0072257) regulation of metanephric nephron tubule epithelial cell differentiation(GO:0072307) |
0.3 | 1.0 | GO:0046684 | response to pyrethroid(GO:0046684) |
0.3 | 1.6 | GO:0010587 | miRNA catabolic process(GO:0010587) |
0.3 | 21.2 | GO:0048704 | embryonic skeletal system morphogenesis(GO:0048704) |
0.3 | 1.0 | GO:0038128 | ERBB2 signaling pathway(GO:0038128) |
0.3 | 1.6 | GO:0060040 | retinal bipolar neuron differentiation(GO:0060040) |
0.3 | 1.3 | GO:0042769 | DNA damage response, detection of DNA damage(GO:0042769) |
0.3 | 0.9 | GO:0060017 | parathyroid gland development(GO:0060017) |
0.3 | 0.9 | GO:0060024 | rhythmic synaptic transmission(GO:0060024) |
0.3 | 2.2 | GO:0035881 | amacrine cell differentiation(GO:0035881) |
0.3 | 0.9 | GO:2000118 | regulation of sodium-dependent phosphate transport(GO:2000118) |
0.3 | 0.3 | GO:0035247 | peptidyl-arginine omega-N-methylation(GO:0035247) |
0.3 | 4.9 | GO:0001964 | startle response(GO:0001964) |
0.3 | 0.6 | GO:1902075 | cellular response to salt(GO:1902075) |
0.3 | 1.2 | GO:1902261 | positive regulation of delayed rectifier potassium channel activity(GO:1902261) positive regulation of voltage-gated potassium channel activity(GO:1903818) |
0.3 | 0.3 | GO:0021529 | spinal cord oligodendrocyte cell differentiation(GO:0021529) spinal cord oligodendrocyte cell fate specification(GO:0021530) |
0.3 | 0.9 | GO:0015747 | urate transport(GO:0015747) |
0.3 | 4.4 | GO:0016486 | peptide hormone processing(GO:0016486) |
0.3 | 0.3 | GO:0060748 | tertiary branching involved in mammary gland duct morphogenesis(GO:0060748) |
0.3 | 0.3 | GO:0061054 | dermatome development(GO:0061054) regulation of dermatome development(GO:0061183) |
0.3 | 0.3 | GO:0009912 | auditory receptor cell fate commitment(GO:0009912) inner ear receptor cell fate commitment(GO:0060120) |
0.3 | 0.6 | GO:0022007 | neural plate elongation(GO:0014022) convergent extension involved in neural plate elongation(GO:0022007) |
0.3 | 0.3 | GO:0010908 | regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010908) positive regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010909) positive regulation of proteoglycan biosynthetic process(GO:1902730) |
0.3 | 0.9 | GO:0006564 | L-serine biosynthetic process(GO:0006564) |
0.3 | 3.7 | GO:0061162 | establishment of monopolar cell polarity(GO:0061162) establishment or maintenance of monopolar cell polarity(GO:0061339) |
0.3 | 1.4 | GO:0014028 | notochord formation(GO:0014028) |
0.3 | 1.4 | GO:0051121 | hepoxilin metabolic process(GO:0051121) hepoxilin biosynthetic process(GO:0051122) |
0.3 | 0.6 | GO:0071873 | response to norepinephrine(GO:0071873) |
0.3 | 0.3 | GO:0022028 | tangential migration from the subventricular zone to the olfactory bulb(GO:0022028) |
0.3 | 2.5 | GO:0035414 | negative regulation of catenin import into nucleus(GO:0035414) |
0.3 | 4.8 | GO:0071475 | cellular hyperosmotic salinity response(GO:0071475) |
0.3 | 0.6 | GO:1901535 | regulation of DNA demethylation(GO:1901535) negative regulation of DNA demethylation(GO:1901536) |
0.3 | 0.3 | GO:0048861 | leukemia inhibitory factor signaling pathway(GO:0048861) |
0.3 | 0.6 | GO:0090427 | activation of meiosis(GO:0090427) |
0.3 | 0.8 | GO:0006553 | lysine metabolic process(GO:0006553) |
0.3 | 1.1 | GO:0061484 | hematopoietic stem cell homeostasis(GO:0061484) |
0.3 | 0.8 | GO:0007494 | midgut development(GO:0007494) |
0.3 | 0.6 | GO:0061047 | positive regulation of branching involved in lung morphogenesis(GO:0061047) |
0.3 | 1.1 | GO:0007158 | neuron cell-cell adhesion(GO:0007158) |
0.3 | 0.3 | GO:0051964 | negative regulation of synapse assembly(GO:0051964) |
0.3 | 0.8 | GO:0032289 | central nervous system myelin formation(GO:0032289) |
0.3 | 0.8 | GO:0019747 | regulation of isoprenoid metabolic process(GO:0019747) |
0.3 | 0.8 | GO:0001546 | preantral ovarian follicle growth(GO:0001546) multi-layer follicle stage(GO:0048162) |
0.3 | 2.2 | GO:0015812 | gamma-aminobutyric acid transport(GO:0015812) |
0.3 | 1.1 | GO:0046499 | S-adenosylmethioninamine metabolic process(GO:0046499) |
0.3 | 0.5 | GO:0034969 | histone arginine methylation(GO:0034969) |
0.3 | 4.2 | GO:0021884 | forebrain neuron development(GO:0021884) |
0.3 | 0.3 | GO:0034633 | retinol transport(GO:0034633) isoprenoid transport(GO:0046864) terpenoid transport(GO:0046865) |
0.3 | 0.5 | GO:0042538 | hyperosmotic salinity response(GO:0042538) |
0.3 | 1.6 | GO:0031915 | positive regulation of synaptic plasticity(GO:0031915) |
0.3 | 0.8 | GO:0034628 | nicotinamide nucleotide biosynthetic process from aspartate(GO:0019355) 'de novo' NAD biosynthetic process from aspartate(GO:0034628) |
0.3 | 0.3 | GO:0045448 | regulation of mitotic cell cycle, embryonic(GO:0009794) mitotic cell cycle, embryonic(GO:0045448) |
0.3 | 0.8 | GO:0060478 | acrosomal vesicle exocytosis(GO:0060478) |
0.3 | 0.8 | GO:0009629 | response to gravity(GO:0009629) |
0.3 | 0.8 | GO:0010046 | response to mycotoxin(GO:0010046) |
0.3 | 0.8 | GO:0018364 | peptidyl-glutamine methylation(GO:0018364) |
0.2 | 0.7 | GO:0043587 | tongue morphogenesis(GO:0043587) |
0.2 | 1.2 | GO:0090336 | positive regulation of brown fat cell differentiation(GO:0090336) |
0.2 | 0.2 | GO:0021938 | smoothened signaling pathway involved in regulation of cerebellar granule cell precursor cell proliferation(GO:0021938) |
0.2 | 0.7 | GO:0034729 | histone H3-K79 methylation(GO:0034729) |
0.2 | 0.2 | GO:0032227 | negative regulation of synaptic transmission, dopaminergic(GO:0032227) |
0.2 | 0.5 | GO:0090493 | catecholamine uptake(GO:0090493) dopamine uptake(GO:0090494) |
0.2 | 1.7 | GO:0048672 | positive regulation of collateral sprouting(GO:0048672) |
0.2 | 1.0 | GO:0050689 | negative regulation of defense response to virus by host(GO:0050689) |
0.2 | 1.2 | GO:2000463 | positive regulation of excitatory postsynaptic potential(GO:2000463) |
0.2 | 0.2 | GO:0042249 | establishment of planar polarity of embryonic epithelium(GO:0042249) |
0.2 | 1.4 | GO:0042985 | negative regulation of amyloid precursor protein biosynthetic process(GO:0042985) |
0.2 | 0.5 | GO:0035860 | glial cell-derived neurotrophic factor receptor signaling pathway(GO:0035860) |
0.2 | 5.3 | GO:0048706 | embryonic skeletal system development(GO:0048706) |
0.2 | 1.0 | GO:0038030 | non-canonical Wnt signaling pathway via MAPK cascade(GO:0038030) non-canonical Wnt signaling pathway via JNK cascade(GO:0038031) |
0.2 | 1.2 | GO:0071321 | response to cGMP(GO:0070305) cellular response to cGMP(GO:0071321) |
0.2 | 1.2 | GO:0014807 | regulation of somitogenesis(GO:0014807) |
0.2 | 0.5 | GO:2000821 | regulation of grooming behavior(GO:2000821) |
0.2 | 0.5 | GO:0051385 | response to mineralocorticoid(GO:0051385) |
0.2 | 2.5 | GO:0060074 | synapse maturation(GO:0060074) |
0.2 | 0.5 | GO:0072160 | nephron tubule epithelial cell differentiation(GO:0072160) |
0.2 | 0.5 | GO:0060084 | synaptic transmission involved in micturition(GO:0060084) |
0.2 | 0.7 | GO:0090289 | regulation of osteoclast proliferation(GO:0090289) |
0.2 | 0.7 | GO:0043985 | histone H4-R3 methylation(GO:0043985) |
0.2 | 0.5 | GO:0071672 | negative regulation of smooth muscle cell chemotaxis(GO:0071672) |
0.2 | 0.7 | GO:1904398 | positive regulation of neuromuscular junction development(GO:1904398) |
0.2 | 1.6 | GO:0060012 | synaptic transmission, glycinergic(GO:0060012) |
0.2 | 0.7 | GO:0060112 | generation of ovulation cycle rhythm(GO:0060112) |
0.2 | 0.2 | GO:0097154 | GABAergic neuron differentiation(GO:0097154) |
0.2 | 0.7 | GO:1904742 | regulation of telomeric DNA binding(GO:1904742) |
0.2 | 1.1 | GO:0015722 | canalicular bile acid transport(GO:0015722) |
0.2 | 0.7 | GO:0045897 | regulation of transcription during mitosis(GO:0045896) positive regulation of transcription during mitosis(GO:0045897) |
0.2 | 0.4 | GO:0007403 | glial cell fate determination(GO:0007403) |
0.2 | 0.7 | GO:0070634 | transepithelial ammonium transport(GO:0070634) |
0.2 | 1.3 | GO:0090385 | phagosome-lysosome fusion(GO:0090385) |
0.2 | 0.4 | GO:0002175 | protein localization to paranode region of axon(GO:0002175) protein localization to axon(GO:0099612) |
0.2 | 0.4 | GO:0070777 | D-aspartate transport(GO:0070777) D-aspartate import(GO:0070779) |
0.2 | 0.4 | GO:0007386 | compartment pattern specification(GO:0007386) |
0.2 | 0.4 | GO:0021999 | neural plate anterior/posterior regionalization(GO:0021999) |
0.2 | 0.9 | GO:0035095 | behavioral response to nicotine(GO:0035095) |
0.2 | 0.4 | GO:2000599 | regulation of cyclin catabolic process(GO:2000598) negative regulation of cyclin catabolic process(GO:2000599) |
0.2 | 0.6 | GO:0072051 | juxtaglomerular apparatus development(GO:0072051) |
0.2 | 0.4 | GO:0038026 | reelin-mediated signaling pathway(GO:0038026) |
0.2 | 1.7 | GO:0009954 | proximal/distal pattern formation(GO:0009954) |
0.2 | 0.4 | GO:0070947 | neutrophil mediated killing of fungus(GO:0070947) |
0.2 | 0.4 | GO:1902036 | regulation of hematopoietic stem cell differentiation(GO:1902036) |
0.2 | 1.0 | GO:0010172 | embryonic body morphogenesis(GO:0010172) |
0.2 | 2.1 | GO:0070050 | neuron cellular homeostasis(GO:0070050) |
0.2 | 2.7 | GO:0048714 | positive regulation of oligodendrocyte differentiation(GO:0048714) |
0.2 | 0.6 | GO:1902268 | negative regulation of polyamine transmembrane transport(GO:1902268) |
0.2 | 0.2 | GO:0002752 | cell surface pattern recognition receptor signaling pathway(GO:0002752) |
0.2 | 0.8 | GO:0098910 | regulation of atrial cardiac muscle cell action potential(GO:0098910) |
0.2 | 0.2 | GO:0016539 | intein-mediated protein splicing(GO:0016539) protein splicing(GO:0030908) |
0.2 | 0.4 | GO:2000765 | regulation of cytoplasmic translation(GO:2000765) |
0.2 | 0.6 | GO:0010387 | COP9 signalosome assembly(GO:0010387) |
0.2 | 9.7 | GO:0051965 | positive regulation of synapse assembly(GO:0051965) |
0.2 | 0.4 | GO:1903660 | regulation of complement-dependent cytotoxicity(GO:1903659) negative regulation of complement-dependent cytotoxicity(GO:1903660) |
0.2 | 0.4 | GO:1902606 | regulation of large conductance calcium-activated potassium channel activity(GO:1902606) positive regulation of large conductance calcium-activated potassium channel activity(GO:1902608) |
0.2 | 1.2 | GO:0090103 | cochlea morphogenesis(GO:0090103) |
0.2 | 1.6 | GO:0034776 | response to histamine(GO:0034776) cellular response to histamine(GO:0071420) |
0.2 | 0.4 | GO:0021957 | corticospinal tract morphogenesis(GO:0021957) |
0.2 | 0.8 | GO:0006563 | L-serine metabolic process(GO:0006563) |
0.2 | 0.2 | GO:0021984 | adenohypophysis development(GO:0021984) |
0.2 | 0.4 | GO:0018992 | germ-line sex determination(GO:0018992) |
0.2 | 0.4 | GO:0014734 | skeletal muscle hypertrophy(GO:0014734) |
0.2 | 0.6 | GO:0009957 | epidermal cell fate specification(GO:0009957) |
0.2 | 0.6 | GO:0031296 | B cell costimulation(GO:0031296) |
0.2 | 0.4 | GO:0048148 | behavioral response to cocaine(GO:0048148) |
0.2 | 0.9 | GO:0035469 | determination of pancreatic left/right asymmetry(GO:0035469) |
0.2 | 0.6 | GO:0097195 | pilomotor reflex(GO:0097195) |
0.2 | 1.9 | GO:0031507 | heterochromatin assembly(GO:0031507) |
0.2 | 0.9 | GO:0021936 | regulation of cerebellar granule cell precursor proliferation(GO:0021936) |
0.2 | 0.2 | GO:0021855 | hypothalamus cell migration(GO:0021855) |
0.2 | 0.6 | GO:0086046 | membrane depolarization during SA node cell action potential(GO:0086046) |
0.2 | 0.4 | GO:0021869 | forebrain ventricular zone progenitor cell division(GO:0021869) |
0.2 | 1.3 | GO:0008038 | neuron recognition(GO:0008038) |
0.2 | 0.6 | GO:1904378 | maintenance of unfolded protein(GO:0036506) maintenance of unfolded protein involved in ERAD pathway(GO:1904378) |
0.2 | 0.9 | GO:0048681 | negative regulation of axon regeneration(GO:0048681) |
0.2 | 0.2 | GO:0060075 | regulation of resting membrane potential(GO:0060075) |
0.2 | 0.2 | GO:0042414 | epinephrine metabolic process(GO:0042414) |
0.2 | 0.4 | GO:0021854 | hypothalamus development(GO:0021854) |
0.2 | 4.8 | GO:0019228 | neuronal action potential(GO:0019228) |
0.2 | 0.5 | GO:0070948 | regulation of neutrophil mediated cytotoxicity(GO:0070948) regulation of neutrophil mediated killing of symbiont cell(GO:0070949) |
0.2 | 0.9 | GO:0030263 | apoptotic chromosome condensation(GO:0030263) |
0.2 | 1.6 | GO:2000311 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000311) |
0.2 | 0.5 | GO:0045585 | regulation of cytotoxic T cell differentiation(GO:0045583) positive regulation of cytotoxic T cell differentiation(GO:0045585) |
0.2 | 0.5 | GO:0046951 | ketone body biosynthetic process(GO:0046951) |
0.2 | 0.3 | GO:0034287 | detection of carbohydrate stimulus(GO:0009730) detection of hexose stimulus(GO:0009732) detection of monosaccharide stimulus(GO:0034287) detection of glucose(GO:0051594) |
0.2 | 0.3 | GO:0030916 | otic vesicle formation(GO:0030916) |
0.2 | 1.2 | GO:0071493 | cellular response to UV-B(GO:0071493) |
0.2 | 0.3 | GO:2000017 | positive regulation of determination of dorsal identity(GO:2000017) |
0.2 | 0.3 | GO:0007220 | Notch receptor processing(GO:0007220) |
0.2 | 0.8 | GO:0032482 | Rab protein signal transduction(GO:0032482) |
0.2 | 3.7 | GO:0048791 | calcium ion-regulated exocytosis of neurotransmitter(GO:0048791) |
0.2 | 0.5 | GO:1900226 | negative regulation of NLRP3 inflammasome complex assembly(GO:1900226) |
0.2 | 0.2 | GO:0061031 | endodermal digestive tract morphogenesis(GO:0061031) |
0.2 | 0.3 | GO:2000767 | positive regulation of cytoplasmic translation(GO:2000767) |
0.2 | 1.2 | GO:0001504 | neurotransmitter uptake(GO:0001504) |
0.2 | 2.1 | GO:1902668 | negative regulation of axon extension involved in axon guidance(GO:0048843) negative regulation of axon guidance(GO:1902668) |
0.2 | 0.8 | GO:0072674 | multinuclear osteoclast differentiation(GO:0072674) |
0.2 | 0.6 | GO:0051126 | negative regulation of actin nucleation(GO:0051126) |
0.2 | 0.6 | GO:1903215 | negative regulation of protein targeting to mitochondrion(GO:1903215) |
0.2 | 0.2 | GO:0061626 | pharyngeal arch artery morphogenesis(GO:0061626) |
0.2 | 0.5 | GO:0046340 | diacylglycerol catabolic process(GO:0046340) |
0.2 | 0.6 | GO:0007199 | G-protein coupled receptor signaling pathway coupled to cGMP nucleotide second messenger(GO:0007199) |
0.2 | 2.5 | GO:0007214 | gamma-aminobutyric acid signaling pathway(GO:0007214) |
0.2 | 0.6 | GO:0006551 | leucine metabolic process(GO:0006551) |
0.2 | 0.5 | GO:0006420 | arginyl-tRNA aminoacylation(GO:0006420) |
0.2 | 0.3 | GO:0090271 | positive regulation of fibroblast growth factor production(GO:0090271) |
0.2 | 0.5 | GO:0033600 | negative regulation of mammary gland epithelial cell proliferation(GO:0033600) |
0.2 | 0.2 | GO:0048319 | axial mesoderm morphogenesis(GO:0048319) |
0.2 | 0.5 | GO:0033122 | negative regulation of purine nucleotide catabolic process(GO:0033122) |
0.2 | 0.8 | GO:1900016 | negative regulation of cytokine production involved in inflammatory response(GO:1900016) |
0.2 | 0.2 | GO:0048022 | negative regulation of melanin biosynthetic process(GO:0048022) negative regulation of secondary metabolite biosynthetic process(GO:1900377) |
0.2 | 0.3 | GO:0016080 | synaptic vesicle targeting(GO:0016080) |
0.1 | 2.7 | GO:2001222 | regulation of neuron migration(GO:2001222) |
0.1 | 0.3 | GO:1902498 | regulation of protein autoubiquitination(GO:1902498) |
0.1 | 0.4 | GO:0046341 | CDP-diacylglycerol metabolic process(GO:0046341) |
0.1 | 0.4 | GO:0070889 | platelet alpha granule organization(GO:0070889) |
0.1 | 0.6 | GO:0006627 | protein processing involved in protein targeting to mitochondrion(GO:0006627) |
0.1 | 1.0 | GO:0030644 | cellular chloride ion homeostasis(GO:0030644) |
0.1 | 0.7 | GO:0030259 | lipid glycosylation(GO:0030259) |
0.1 | 2.9 | GO:0048013 | ephrin receptor signaling pathway(GO:0048013) |
0.1 | 0.1 | GO:0023041 | neuronal signal transduction(GO:0023041) |
0.1 | 10.4 | GO:0007156 | homophilic cell adhesion via plasma membrane adhesion molecules(GO:0007156) |
0.1 | 0.6 | GO:1903626 | positive regulation of apoptotic DNA fragmentation(GO:1902512) positive regulation of DNA catabolic process(GO:1903626) |
0.1 | 0.3 | GO:1902445 | regulation of mitochondrial membrane permeability involved in programmed necrotic cell death(GO:1902445) |
0.1 | 0.4 | GO:0006438 | valyl-tRNA aminoacylation(GO:0006438) |
0.1 | 0.6 | GO:2000503 | positive regulation of natural killer cell chemotaxis(GO:2000503) |
0.1 | 1.7 | GO:0003417 | growth plate cartilage development(GO:0003417) |
0.1 | 0.7 | GO:0031293 | membrane protein intracellular domain proteolysis(GO:0031293) |
0.1 | 0.4 | GO:0080154 | regulation of fertilization(GO:0080154) |
0.1 | 0.1 | GO:0030538 | embryonic genitalia morphogenesis(GO:0030538) |
0.1 | 0.7 | GO:0031937 | positive regulation of chromatin silencing(GO:0031937) |
0.1 | 1.0 | GO:0021895 | cerebral cortex neuron differentiation(GO:0021895) |
0.1 | 0.3 | GO:0060371 | regulation of atrial cardiac muscle cell membrane depolarization(GO:0060371) |
0.1 | 0.6 | GO:2000574 | regulation of microtubule motor activity(GO:2000574) |
0.1 | 1.5 | GO:0046549 | retinal cone cell development(GO:0046549) |
0.1 | 0.1 | GO:0039533 | regulation of MDA-5 signaling pathway(GO:0039533) |
0.1 | 0.4 | GO:0006382 | adenosine to inosine editing(GO:0006382) |
0.1 | 0.8 | GO:0007168 | receptor guanylyl cyclase signaling pathway(GO:0007168) |
0.1 | 0.8 | GO:0090557 | establishment of endothelial intestinal barrier(GO:0090557) |
0.1 | 2.5 | GO:0060997 | dendritic spine morphogenesis(GO:0060997) |
0.1 | 0.4 | GO:1900245 | positive regulation of MDA-5 signaling pathway(GO:1900245) |
0.1 | 0.3 | GO:0006562 | proline catabolic process(GO:0006562) |
0.1 | 0.8 | GO:0001975 | response to amphetamine(GO:0001975) |
0.1 | 0.4 | GO:0046439 | cysteine catabolic process(GO:0009093) L-cysteine catabolic process(GO:0019448) L-cysteine metabolic process(GO:0046439) |
0.1 | 0.5 | GO:0051365 | cellular response to potassium ion starvation(GO:0051365) |
0.1 | 1.0 | GO:0014059 | dopamine secretion(GO:0014046) regulation of dopamine secretion(GO:0014059) |
0.1 | 0.4 | GO:0060363 | cranial suture morphogenesis(GO:0060363) |
0.1 | 0.6 | GO:0048251 | elastic fiber assembly(GO:0048251) |
0.1 | 0.4 | GO:0090135 | actin filament branching(GO:0090135) |
0.1 | 0.3 | GO:0014901 | regulation of satellite cell activation involved in skeletal muscle regeneration(GO:0014717) satellite cell activation involved in skeletal muscle regeneration(GO:0014901) |
0.1 | 0.9 | GO:0070253 | somatostatin secretion(GO:0070253) |
0.1 | 1.5 | GO:0048268 | clathrin coat assembly(GO:0048268) |
0.1 | 0.1 | GO:0070094 | positive regulation of glucagon secretion(GO:0070094) |
0.1 | 0.4 | GO:0006048 | UDP-N-acetylglucosamine biosynthetic process(GO:0006048) |
0.1 | 0.5 | GO:0000395 | mRNA 5'-splice site recognition(GO:0000395) |
0.1 | 0.5 | GO:0010626 | negative regulation of Schwann cell proliferation(GO:0010626) |
0.1 | 0.4 | GO:1902805 | positive regulation of synaptic vesicle transport(GO:1902805) |
0.1 | 0.2 | GO:1990035 | calcium ion import into cell(GO:1990035) |
0.1 | 0.1 | GO:0072553 | terminal button organization(GO:0072553) |
0.1 | 0.2 | GO:0051661 | maintenance of centrosome location(GO:0051661) |
0.1 | 0.2 | GO:1902309 | negative regulation of peptidyl-serine dephosphorylation(GO:1902309) |
0.1 | 0.2 | GO:0034443 | negative regulation of lipoprotein oxidation(GO:0034443) |
0.1 | 0.4 | GO:0035280 | miRNA loading onto RISC involved in gene silencing by miRNA(GO:0035280) |
0.1 | 1.7 | GO:0030322 | stabilization of membrane potential(GO:0030322) |
0.1 | 0.6 | GO:0003416 | endochondral bone growth(GO:0003416) |
0.1 | 0.5 | GO:2000344 | positive regulation of acrosome reaction(GO:2000344) |
0.1 | 0.4 | GO:0002378 | immunoglobulin biosynthetic process(GO:0002378) |
0.1 | 6.6 | GO:0007218 | neuropeptide signaling pathway(GO:0007218) |
0.1 | 0.7 | GO:0036289 | peptidyl-serine autophosphorylation(GO:0036289) |
0.1 | 0.7 | GO:0050908 | detection of light stimulus involved in visual perception(GO:0050908) detection of light stimulus involved in sensory perception(GO:0050962) |
0.1 | 0.4 | GO:0008065 | establishment of blood-nerve barrier(GO:0008065) |
0.1 | 0.6 | GO:0015884 | folic acid transport(GO:0015884) |
0.1 | 0.1 | GO:0072108 | positive regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis(GO:0072108) |
0.1 | 0.2 | GO:0042940 | D-amino acid transport(GO:0042940) |
0.1 | 0.2 | GO:0035106 | operant conditioning(GO:0035106) |
0.1 | 0.4 | GO:1902218 | intrinsic apoptotic signaling pathway in response to osmotic stress(GO:0008627) regulation of intrinsic apoptotic signaling pathway in response to osmotic stress(GO:1902218) negative regulation of intrinsic apoptotic signaling pathway in response to osmotic stress(GO:1902219) |
0.1 | 0.4 | GO:0019287 | isopentenyl diphosphate biosynthetic process(GO:0009240) isopentenyl diphosphate biosynthetic process, mevalonate pathway(GO:0019287) |
0.1 | 0.4 | GO:0042136 | neurotransmitter biosynthetic process(GO:0042136) |
0.1 | 0.7 | GO:0042590 | antigen processing and presentation of exogenous peptide antigen via MHC class I(GO:0042590) |
0.1 | 0.5 | GO:0031053 | primary miRNA processing(GO:0031053) |
0.1 | 0.3 | GO:2001168 | regulation of histone H2B ubiquitination(GO:2001166) positive regulation of histone H2B ubiquitination(GO:2001168) |
0.1 | 0.6 | GO:0070831 | basement membrane assembly(GO:0070831) |
0.1 | 0.3 | GO:0015871 | choline transport(GO:0015871) |
0.1 | 0.3 | GO:0038044 | transforming growth factor-beta secretion(GO:0038044) regulation of transforming growth factor-beta secretion(GO:2001201) |
0.1 | 1.5 | GO:0071526 | semaphorin-plexin signaling pathway(GO:0071526) |
0.1 | 0.9 | GO:0060732 | positive regulation of inositol phosphate biosynthetic process(GO:0060732) |
0.1 | 0.3 | GO:0044860 | protein localization to plasma membrane raft(GO:0044860) |
0.1 | 0.9 | GO:0051654 | establishment of mitochondrion localization(GO:0051654) |
0.1 | 0.3 | GO:0006296 | nucleotide-excision repair, DNA incision, 5'-to lesion(GO:0006296) |
0.1 | 0.8 | GO:0070417 | cellular response to cold(GO:0070417) |
0.1 | 1.3 | GO:0050650 | chondroitin sulfate proteoglycan biosynthetic process(GO:0050650) |
0.1 | 0.2 | GO:0045162 | clustering of voltage-gated sodium channels(GO:0045162) |
0.1 | 0.1 | GO:0071910 | determination of liver left/right asymmetry(GO:0071910) |
0.1 | 0.3 | GO:0006642 | triglyceride mobilization(GO:0006642) |
0.1 | 0.4 | GO:0070120 | ciliary neurotrophic factor-mediated signaling pathway(GO:0070120) |
0.1 | 0.2 | GO:0044341 | sodium-dependent phosphate transport(GO:0044341) |
0.1 | 0.4 | GO:0021542 | dentate gyrus development(GO:0021542) |
0.1 | 0.4 | GO:0051919 | positive regulation of fibrinolysis(GO:0051919) |
0.1 | 0.2 | GO:0060385 | axonogenesis involved in innervation(GO:0060385) |
0.1 | 0.5 | GO:0034227 | tRNA thio-modification(GO:0034227) |
0.1 | 0.5 | GO:0043584 | nose development(GO:0043584) |
0.1 | 0.1 | GO:0042891 | antibiotic transport(GO:0042891) |
0.1 | 0.3 | GO:0010288 | response to lead ion(GO:0010288) |
0.1 | 0.9 | GO:2000052 | positive regulation of non-canonical Wnt signaling pathway(GO:2000052) |
0.1 | 0.4 | GO:0046013 | T cell homeostatic proliferation(GO:0001777) regulation of T cell homeostatic proliferation(GO:0046013) |
0.1 | 0.3 | GO:0009128 | purine nucleoside monophosphate catabolic process(GO:0009128) |
0.1 | 0.4 | GO:0051136 | regulation of NK T cell differentiation(GO:0051136) positive regulation of NK T cell differentiation(GO:0051138) |
0.1 | 0.7 | GO:0051764 | actin crosslink formation(GO:0051764) |
0.1 | 0.2 | GO:0044828 | negative regulation by host of viral genome replication(GO:0044828) |
0.1 | 1.2 | GO:0006044 | N-acetylglucosamine metabolic process(GO:0006044) |
0.1 | 1.3 | GO:0048025 | negative regulation of mRNA splicing, via spliceosome(GO:0048025) |
0.1 | 1.0 | GO:0031115 | negative regulation of microtubule polymerization(GO:0031115) |
0.1 | 0.2 | GO:0010535 | positive regulation of activation of JAK2 kinase activity(GO:0010535) |
0.1 | 0.2 | GO:0060266 | negative regulation of respiratory burst involved in inflammatory response(GO:0060266) |
0.1 | 0.2 | GO:0002426 | immunoglobulin production in mucosal tissue(GO:0002426) |
0.1 | 0.1 | GO:0030656 | regulation of vitamin metabolic process(GO:0030656) |
0.1 | 0.3 | GO:0072531 | pyrimidine-containing compound transmembrane transport(GO:0072531) |
0.1 | 0.3 | GO:1904694 | negative regulation of vascular smooth muscle contraction(GO:1904694) |
0.1 | 0.7 | GO:0099515 | actin filament-based transport(GO:0099515) |
0.1 | 0.4 | GO:1900107 | regulation of nodal signaling pathway(GO:1900107) |
0.1 | 0.3 | GO:0071638 | negative regulation of monocyte chemotactic protein-1 production(GO:0071638) |
0.1 | 0.2 | GO:2000359 | regulation of binding of sperm to zona pellucida(GO:2000359) |
0.1 | 1.1 | GO:0021522 | spinal cord motor neuron differentiation(GO:0021522) |
0.1 | 0.2 | GO:0071542 | dopaminergic neuron differentiation(GO:0071542) |
0.1 | 0.2 | GO:0015014 | heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0015014) |
0.1 | 0.2 | GO:0072093 | metanephric renal vesicle formation(GO:0072093) |
0.1 | 0.2 | GO:0006419 | alanyl-tRNA aminoacylation(GO:0006419) |
0.1 | 0.2 | GO:0010446 | response to alkaline pH(GO:0010446) |
0.1 | 0.2 | GO:0021540 | corpus callosum morphogenesis(GO:0021540) |
0.1 | 0.4 | GO:0035234 | ectopic germ cell programmed cell death(GO:0035234) |
0.1 | 0.1 | GO:0010919 | regulation of inositol phosphate biosynthetic process(GO:0010919) |
0.1 | 0.1 | GO:1901503 | ether lipid biosynthetic process(GO:0008611) glycerol ether biosynthetic process(GO:0046504) cellular lipid biosynthetic process(GO:0097384) ether biosynthetic process(GO:1901503) |
0.1 | 0.2 | GO:2000586 | regulation of platelet-derived growth factor receptor-beta signaling pathway(GO:2000586) negative regulation of platelet-derived growth factor receptor-beta signaling pathway(GO:2000587) |
0.1 | 0.4 | GO:0018101 | protein citrullination(GO:0018101) |
0.1 | 2.7 | GO:1902476 | chloride transmembrane transport(GO:1902476) |
0.1 | 0.3 | GO:1905098 | negative regulation of guanyl-nucleotide exchange factor activity(GO:1905098) |
0.1 | 0.3 | GO:2001184 | positive regulation of interleukin-12 secretion(GO:2001184) |
0.1 | 0.4 | GO:0035902 | response to immobilization stress(GO:0035902) |
0.1 | 0.2 | GO:0009125 | nucleoside monophosphate catabolic process(GO:0009125) |
0.1 | 0.2 | GO:2001013 | epithelial cell proliferation involved in renal tubule morphogenesis(GO:2001013) |
0.1 | 0.2 | GO:0060700 | regulation of ribonuclease activity(GO:0060700) |
0.1 | 0.5 | GO:0006703 | estrogen biosynthetic process(GO:0006703) |
0.1 | 0.4 | GO:0045650 | negative regulation of macrophage differentiation(GO:0045650) |
0.1 | 0.4 | GO:1902953 | positive regulation of ER to Golgi vesicle-mediated transport(GO:1902953) |
0.1 | 0.1 | GO:0035993 | deltoid tuberosity development(GO:0035993) |
0.1 | 0.6 | GO:0045687 | positive regulation of glial cell differentiation(GO:0045687) |
0.1 | 1.1 | GO:0048026 | positive regulation of mRNA splicing, via spliceosome(GO:0048026) |
0.1 | 0.5 | GO:0048387 | negative regulation of retinoic acid receptor signaling pathway(GO:0048387) |
0.1 | 0.4 | GO:0035878 | nail development(GO:0035878) |
0.1 | 0.4 | GO:0006776 | vitamin A metabolic process(GO:0006776) |
0.1 | 0.4 | GO:0033762 | response to glucagon(GO:0033762) |
0.1 | 0.2 | GO:0050717 | positive regulation of interleukin-1 alpha secretion(GO:0050717) |
0.1 | 0.5 | GO:0035116 | embryonic hindlimb morphogenesis(GO:0035116) |
0.1 | 1.6 | GO:0042462 | eye photoreceptor cell development(GO:0042462) |
0.1 | 0.3 | GO:0031446 | regulation of fast-twitch skeletal muscle fiber contraction(GO:0031446) positive regulation of fast-twitch skeletal muscle fiber contraction(GO:0031448) |
0.1 | 0.6 | GO:0048488 | synaptic vesicle endocytosis(GO:0048488) |
0.1 | 1.0 | GO:0021766 | hippocampus development(GO:0021766) |
0.1 | 0.3 | GO:0060384 | innervation(GO:0060384) |
0.1 | 0.3 | GO:0042276 | error-prone translesion synthesis(GO:0042276) |
0.1 | 0.1 | GO:0021914 | negative regulation of smoothened signaling pathway involved in ventral spinal cord patterning(GO:0021914) |
0.1 | 0.1 | GO:0034441 | plasma lipoprotein particle oxidation(GO:0034441) |
0.1 | 0.2 | GO:1901078 | negative regulation of relaxation of muscle(GO:1901078) |
0.1 | 0.1 | GO:0098904 | regulation of AV node cell action potential(GO:0098904) |
0.1 | 0.1 | GO:0035524 | proline transmembrane transport(GO:0035524) |
0.1 | 4.1 | GO:0001764 | neuron migration(GO:0001764) |
0.1 | 0.1 | GO:0015870 | acetylcholine transport(GO:0015870) acetate ester transport(GO:1901374) |
0.1 | 0.2 | GO:0051388 | positive regulation of neurotrophin TRK receptor signaling pathway(GO:0051388) |
0.1 | 0.2 | GO:0060648 | mammary gland bud morphogenesis(GO:0060648) |
0.1 | 0.2 | GO:0060501 | positive regulation of epithelial cell proliferation involved in lung morphogenesis(GO:0060501) |
0.1 | 0.4 | GO:0007379 | segment specification(GO:0007379) |
0.1 | 0.2 | GO:0001698 | gastrin-induced gastric acid secretion(GO:0001698) |
0.1 | 0.2 | GO:0060339 | negative regulation of type I interferon-mediated signaling pathway(GO:0060339) |
0.1 | 0.4 | GO:0098743 | cartilage condensation(GO:0001502) cell aggregation(GO:0098743) |
0.1 | 0.2 | GO:0033605 | positive regulation of catecholamine secretion(GO:0033605) |
0.1 | 0.2 | GO:0003383 | apical constriction(GO:0003383) |
0.1 | 0.1 | GO:0033121 | regulation of purine nucleotide catabolic process(GO:0033121) |
0.1 | 0.4 | GO:0060088 | auditory receptor cell stereocilium organization(GO:0060088) |
0.1 | 0.2 | GO:0045080 | positive regulation of chemokine biosynthetic process(GO:0045080) |
0.1 | 0.4 | GO:0022615 | protein to membrane docking(GO:0022615) |
0.1 | 0.1 | GO:0061101 | neuroendocrine cell differentiation(GO:0061101) |
0.1 | 0.2 | GO:0060179 | male mating behavior(GO:0060179) |
0.1 | 1.1 | GO:0006379 | mRNA cleavage(GO:0006379) |
0.1 | 1.0 | GO:0007616 | long-term memory(GO:0007616) |
0.1 | 2.0 | GO:0050885 | neuromuscular process controlling balance(GO:0050885) |
0.1 | 0.2 | GO:0048715 | negative regulation of oligodendrocyte differentiation(GO:0048715) |
0.1 | 0.3 | GO:0042138 | meiotic DNA double-strand break formation(GO:0042138) |
0.1 | 0.2 | GO:0035964 | COPI-coated vesicle budding(GO:0035964) |
0.1 | 0.2 | GO:0044778 | meiotic DNA integrity checkpoint(GO:0044778) |
0.1 | 0.3 | GO:0022010 | central nervous system myelination(GO:0022010) axon ensheathment in central nervous system(GO:0032291) |
0.1 | 0.2 | GO:0032202 | telomere assembly(GO:0032202) |
0.1 | 0.2 | GO:0060244 | negative regulation of cell proliferation involved in contact inhibition(GO:0060244) |
0.1 | 0.1 | GO:0043366 | beta selection(GO:0043366) |
0.1 | 0.1 | GO:0071799 | response to prostaglandin D(GO:0071798) cellular response to prostaglandin D stimulus(GO:0071799) |
0.1 | 0.4 | GO:0048304 | positive regulation of isotype switching to IgG isotypes(GO:0048304) |
0.1 | 0.3 | GO:0007210 | serotonin receptor signaling pathway(GO:0007210) |
0.1 | 0.3 | GO:0090080 | positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway(GO:0090080) |
0.1 | 0.1 | GO:2000823 | regulation of androgen receptor activity(GO:2000823) |
0.1 | 0.2 | GO:0045956 | positive regulation of calcium ion-dependent exocytosis(GO:0045956) |
0.1 | 0.4 | GO:0010739 | positive regulation of protein kinase A signaling(GO:0010739) |
0.1 | 0.1 | GO:0070858 | negative regulation of bile acid biosynthetic process(GO:0070858) negative regulation of bile acid metabolic process(GO:1904252) |
0.1 | 0.2 | GO:0097466 | glycoprotein ERAD pathway(GO:0097466) response to glycoprotein(GO:1904587) |
0.1 | 0.5 | GO:0019673 | GDP-mannose metabolic process(GO:0019673) |
0.1 | 0.4 | GO:0045945 | positive regulation of transcription from RNA polymerase III promoter(GO:0045945) |
0.1 | 0.2 | GO:0018094 | protein polyglycylation(GO:0018094) |
0.1 | 0.2 | GO:0042726 | flavin-containing compound metabolic process(GO:0042726) |
0.1 | 0.3 | GO:0010042 | response to manganese ion(GO:0010042) |
0.1 | 0.1 | GO:0007161 | calcium-independent cell-matrix adhesion(GO:0007161) |
0.1 | 0.7 | GO:0051966 | regulation of synaptic transmission, glutamatergic(GO:0051966) |
0.1 | 0.1 | GO:0046485 | ether lipid metabolic process(GO:0046485) |
0.1 | 0.3 | GO:0098535 | de novo centriole assembly(GO:0098535) |
0.1 | 0.4 | GO:0032713 | negative regulation of interleukin-4 production(GO:0032713) |
0.1 | 0.1 | GO:0014816 | skeletal muscle satellite cell differentiation(GO:0014816) |
0.1 | 0.6 | GO:0006346 | methylation-dependent chromatin silencing(GO:0006346) |
0.1 | 0.4 | GO:0071569 | protein ufmylation(GO:0071569) |
0.1 | 0.3 | GO:0070172 | positive regulation of tooth mineralization(GO:0070172) |
0.1 | 0.3 | GO:1903964 | monounsaturated fatty acid metabolic process(GO:1903964) monounsaturated fatty acid biosynthetic process(GO:1903966) |
0.1 | 0.4 | GO:0060122 | inner ear receptor stereocilium organization(GO:0060122) |
0.1 | 0.2 | GO:0006742 | NADP catabolic process(GO:0006742) |
0.1 | 0.1 | GO:0090283 | regulation of protein glycosylation in Golgi(GO:0090283) |
0.1 | 0.6 | GO:0048339 | paraxial mesoderm development(GO:0048339) |
0.1 | 0.1 | GO:0019344 | cysteine biosynthetic process(GO:0019344) |
0.1 | 0.5 | GO:2000060 | positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:2000060) |
0.1 | 0.2 | GO:0030167 | proteoglycan catabolic process(GO:0030167) |
0.1 | 0.1 | GO:0035262 | gonad morphogenesis(GO:0035262) |
0.1 | 0.1 | GO:0019227 | neuronal action potential propagation(GO:0019227) action potential propagation(GO:0098870) |
0.1 | 0.1 | GO:0045988 | negative regulation of striated muscle contraction(GO:0045988) |
0.1 | 0.1 | GO:0014826 | vein smooth muscle contraction(GO:0014826) |
0.1 | 0.7 | GO:0035563 | positive regulation of chromatin binding(GO:0035563) |
0.1 | 0.2 | GO:0090244 | Wnt signaling pathway involved in somitogenesis(GO:0090244) |
0.1 | 0.5 | GO:0042760 | very long-chain fatty acid catabolic process(GO:0042760) |
0.1 | 0.2 | GO:1903204 | negative regulation of oxidative stress-induced neuron death(GO:1903204) |
0.1 | 0.1 | GO:1900186 | negative regulation of clathrin-mediated endocytosis(GO:1900186) |
0.1 | 0.2 | GO:1903862 | positive regulation of oxidative phosphorylation(GO:1903862) |
0.1 | 0.2 | GO:0031052 | programmed DNA elimination(GO:0031049) chromosome breakage(GO:0031052) |
0.1 | 0.2 | GO:0010360 | negative regulation of anion channel activity(GO:0010360) |
0.1 | 0.1 | GO:0000101 | sulfur amino acid transport(GO:0000101) |
0.1 | 0.1 | GO:0002678 | positive regulation of chronic inflammatory response(GO:0002678) |
0.1 | 0.3 | GO:0006477 | protein sulfation(GO:0006477) |
0.1 | 0.1 | GO:2000617 | positive regulation of histone H3-K9 acetylation(GO:2000617) |
0.1 | 0.4 | GO:2001204 | regulation of osteoclast development(GO:2001204) |
0.1 | 0.3 | GO:0007296 | vitellogenesis(GO:0007296) |
0.1 | 0.1 | GO:0060029 | convergent extension involved in organogenesis(GO:0060029) |
0.1 | 0.1 | GO:1904970 | brush border assembly(GO:1904970) |
0.1 | 0.4 | GO:0042989 | sequestering of actin monomers(GO:0042989) |
0.1 | 0.3 | GO:0006012 | galactose metabolic process(GO:0006012) |
0.1 | 0.3 | GO:0006449 | regulation of translational termination(GO:0006449) |
0.1 | 0.1 | GO:0016259 | selenocysteine metabolic process(GO:0016259) |
0.1 | 0.3 | GO:0034047 | regulation of protein phosphatase type 2A activity(GO:0034047) |
0.1 | 0.1 | GO:0035815 | positive regulation of renal sodium excretion(GO:0035815) |
0.1 | 0.2 | GO:1904659 | glucose transmembrane transport(GO:1904659) |
0.1 | 0.4 | GO:0015816 | glycine transport(GO:0015816) |
0.1 | 0.2 | GO:0001835 | blastocyst hatching(GO:0001835) hatching(GO:0035188) organism emergence from protective structure(GO:0071684) |
0.1 | 0.4 | GO:0080182 | histone H3-K4 trimethylation(GO:0080182) |
0.1 | 0.2 | GO:0006987 | activation of signaling protein activity involved in unfolded protein response(GO:0006987) |
0.1 | 0.1 | GO:1901165 | positive regulation of trophoblast cell migration(GO:1901165) |
0.1 | 0.1 | GO:0051599 | response to hydrostatic pressure(GO:0051599) |
0.1 | 0.2 | GO:0016344 | meiotic chromosome movement towards spindle pole(GO:0016344) |
0.1 | 3.8 | GO:0010923 | negative regulation of phosphatase activity(GO:0010923) |
0.1 | 0.4 | GO:0046069 | cGMP catabolic process(GO:0046069) |
0.1 | 0.9 | GO:0034587 | piRNA metabolic process(GO:0034587) |
0.1 | 0.8 | GO:0032012 | ARF protein signal transduction(GO:0032011) regulation of ARF protein signal transduction(GO:0032012) |
0.1 | 0.3 | GO:0016255 | attachment of GPI anchor to protein(GO:0016255) |
0.1 | 0.5 | GO:0034244 | negative regulation of transcription elongation from RNA polymerase II promoter(GO:0034244) |
0.1 | 0.2 | GO:1902410 | mitotic cytokinetic process(GO:1902410) |
0.1 | 0.2 | GO:0006667 | sphinganine metabolic process(GO:0006667) |
0.1 | 0.1 | GO:0048021 | regulation of melanin biosynthetic process(GO:0048021) regulation of secondary metabolite biosynthetic process(GO:1900376) |
0.1 | 0.1 | GO:0031054 | pre-miRNA processing(GO:0031054) |
0.1 | 0.2 | GO:0019464 | glycine catabolic process(GO:0006546) glycine decarboxylation via glycine cleavage system(GO:0019464) |
0.1 | 0.2 | GO:0097211 | response to gonadotropin-releasing hormone(GO:0097210) cellular response to gonadotropin-releasing hormone(GO:0097211) |
0.1 | 0.1 | GO:0043652 | engulfment of apoptotic cell(GO:0043652) |
0.1 | 0.2 | GO:0002017 | regulation of blood volume by renal aldosterone(GO:0002017) |
0.1 | 0.6 | GO:0002347 | response to tumor cell(GO:0002347) |
0.1 | 0.1 | GO:0038033 | positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway(GO:0038033) |
0.1 | 0.1 | GO:0043313 | regulation of neutrophil degranulation(GO:0043313) |
0.1 | 0.5 | GO:0036158 | outer dynein arm assembly(GO:0036158) |
0.1 | 0.2 | GO:0019372 | lipoxygenase pathway(GO:0019372) |
0.1 | 0.1 | GO:0021798 | forebrain dorsal/ventral pattern formation(GO:0021798) |
0.1 | 0.1 | GO:0070571 | negative regulation of neuron projection regeneration(GO:0070571) |
0.1 | 0.2 | GO:1901725 | regulation of histone deacetylase activity(GO:1901725) |
0.1 | 0.2 | GO:0070125 | mitochondrial translational elongation(GO:0070125) |
0.1 | 0.1 | GO:0070346 | positive regulation of fat cell proliferation(GO:0070346) |
0.1 | 0.2 | GO:0015015 | heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
0.1 | 0.2 | GO:0007023 | post-chaperonin tubulin folding pathway(GO:0007023) |
0.1 | 0.4 | GO:0060576 | intestinal epithelial cell development(GO:0060576) |
0.0 | 0.1 | GO:0003352 | regulation of cilium movement(GO:0003352) |
0.0 | 0.1 | GO:0006651 | diacylglycerol biosynthetic process(GO:0006651) |
0.0 | 0.0 | GO:0048294 | negative regulation of isotype switching to IgE isotypes(GO:0048294) |
0.0 | 0.2 | GO:0009249 | protein lipoylation(GO:0009249) |
0.0 | 0.1 | GO:0001880 | Mullerian duct regression(GO:0001880) |
0.0 | 0.5 | GO:0051016 | barbed-end actin filament capping(GO:0051016) |
0.0 | 0.0 | GO:0072205 | metanephric collecting duct development(GO:0072205) |
0.0 | 1.3 | GO:0016079 | synaptic vesicle exocytosis(GO:0016079) |
0.0 | 0.1 | GO:0033499 | galactose catabolic process via UDP-galactose(GO:0033499) glycolytic process from galactose(GO:0061623) |
0.0 | 0.3 | GO:0051131 | chaperone-mediated protein complex assembly(GO:0051131) |
0.0 | 0.3 | GO:1902231 | positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902231) |
0.0 | 0.2 | GO:0035418 | protein localization to synapse(GO:0035418) |
0.0 | 0.6 | GO:0008542 | visual learning(GO:0008542) |
0.0 | 0.1 | GO:2000686 | regulation of rubidium ion transmembrane transporter activity(GO:2000686) |
0.0 | 0.0 | GO:1902308 | regulation of peptidyl-serine dephosphorylation(GO:1902308) |
0.0 | 0.1 | GO:0045875 | negative regulation of sister chromatid cohesion(GO:0045875) |
0.0 | 0.5 | GO:0030224 | monocyte differentiation(GO:0030224) |
0.0 | 0.2 | GO:1902035 | positive regulation of hematopoietic stem cell proliferation(GO:1902035) |
0.0 | 0.1 | GO:1903237 | negative regulation of leukocyte tethering or rolling(GO:1903237) |
0.0 | 0.5 | GO:0042472 | inner ear morphogenesis(GO:0042472) |
0.0 | 0.1 | GO:0060671 | epithelial cell differentiation involved in embryonic placenta development(GO:0060671) epithelial cell morphogenesis involved in placental branching(GO:0060672) |
0.0 | 0.1 | GO:0015705 | iodide transport(GO:0015705) |
0.0 | 0.1 | GO:0001555 | oocyte growth(GO:0001555) |
0.0 | 0.2 | GO:0015712 | hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
0.0 | 0.1 | GO:0015888 | thiamine transport(GO:0015888) |
0.0 | 0.3 | GO:0042359 | vitamin D metabolic process(GO:0042359) |
0.0 | 0.4 | GO:0006622 | protein targeting to lysosome(GO:0006622) |
0.0 | 0.2 | GO:0035269 | protein O-linked mannosylation(GO:0035269) |
0.0 | 0.9 | GO:0007340 | acrosome reaction(GO:0007340) |
0.0 | 0.1 | GO:0006597 | spermine biosynthetic process(GO:0006597) |
0.0 | 0.1 | GO:0015770 | disaccharide transport(GO:0015766) sucrose transport(GO:0015770) oligosaccharide transport(GO:0015772) |
0.0 | 0.2 | GO:0032824 | natural killer cell differentiation involved in immune response(GO:0002325) negative regulation of natural killer cell differentiation(GO:0032824) regulation of natural killer cell differentiation involved in immune response(GO:0032826) negative regulation of natural killer cell differentiation involved in immune response(GO:0032827) |
0.0 | 0.0 | GO:0065001 | specification of axis polarity(GO:0065001) |
0.0 | 0.0 | GO:0017085 | response to insecticide(GO:0017085) |
0.0 | 0.2 | GO:0006526 | arginine biosynthetic process(GO:0006526) |
0.0 | 0.0 | GO:0030432 | peristalsis(GO:0030432) |
0.0 | 0.2 | GO:0042796 | snRNA transcription from RNA polymerase III promoter(GO:0042796) |
0.0 | 0.1 | GO:1903232 | melanosome assembly(GO:1903232) |
0.0 | 0.1 | GO:0016557 | peroxisome membrane biogenesis(GO:0016557) |
0.0 | 0.2 | GO:0006528 | asparagine metabolic process(GO:0006528) |
0.0 | 0.2 | GO:0033129 | positive regulation of histone phosphorylation(GO:0033129) |
0.0 | 0.4 | GO:0003334 | keratinocyte development(GO:0003334) |
0.0 | 0.1 | GO:1904263 | positive regulation of TORC1 signaling(GO:1904263) |
0.0 | 0.0 | GO:0016561 | protein import into peroxisome matrix, translocation(GO:0016561) |
0.0 | 0.0 | GO:0008078 | mesodermal cell migration(GO:0008078) |
0.0 | 0.3 | GO:0061157 | mRNA destabilization(GO:0061157) |
0.0 | 0.1 | GO:0009750 | response to fructose(GO:0009750) |
0.0 | 0.3 | GO:1904294 | positive regulation of ERAD pathway(GO:1904294) |
0.0 | 0.3 | GO:0060294 | cilium movement involved in cell motility(GO:0060294) |
0.0 | 0.1 | GO:0036342 | post-anal tail morphogenesis(GO:0036342) |
0.0 | 0.6 | GO:0006491 | N-glycan processing(GO:0006491) |
0.0 | 0.1 | GO:1902969 | mitotic DNA replication(GO:1902969) |
0.0 | 0.1 | GO:0070309 | lens fiber cell morphogenesis(GO:0070309) |
0.0 | 0.1 | GO:0040037 | negative regulation of fibroblast growth factor receptor signaling pathway(GO:0040037) |
0.0 | 0.2 | GO:0043615 | astrocyte cell migration(GO:0043615) |
0.0 | 0.2 | GO:0050961 | detection of temperature stimulus involved in sensory perception(GO:0050961) detection of temperature stimulus involved in sensory perception of pain(GO:0050965) |
0.0 | 0.4 | GO:0032878 | regulation of establishment or maintenance of cell polarity(GO:0032878) |
0.0 | 0.1 | GO:1902177 | positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway(GO:1902177) |
0.0 | 0.2 | GO:0070286 | axonemal dynein complex assembly(GO:0070286) |
0.0 | 0.1 | GO:0006363 | termination of RNA polymerase I transcription(GO:0006363) |
0.0 | 0.1 | GO:0045917 | positive regulation of complement activation(GO:0045917) positive regulation of protein activation cascade(GO:2000259) |
0.0 | 0.2 | GO:0045721 | negative regulation of gluconeogenesis(GO:0045721) |
0.0 | 0.1 | GO:2000002 | negative regulation of DNA damage checkpoint(GO:2000002) |
0.0 | 0.8 | GO:0006890 | retrograde vesicle-mediated transport, Golgi to ER(GO:0006890) |
0.0 | 0.3 | GO:2001241 | positive regulation of extrinsic apoptotic signaling pathway in absence of ligand(GO:2001241) |
0.0 | 0.1 | GO:0097240 | meiotic telomere tethering at nuclear periphery(GO:0044821) meiotic attachment of telomere to nuclear envelope(GO:0070197) chromosome attachment to the nuclear envelope(GO:0097240) |
0.0 | 0.2 | GO:0021904 | dorsal/ventral neural tube patterning(GO:0021904) |
0.0 | 0.8 | GO:0046839 | phospholipid dephosphorylation(GO:0046839) |
0.0 | 0.3 | GO:0036065 | fucosylation(GO:0036065) |
0.0 | 0.8 | GO:0007019 | microtubule depolymerization(GO:0007019) |
0.0 | 0.6 | GO:0099531 | presynaptic process involved in chemical synaptic transmission(GO:0099531) |
0.0 | 0.1 | GO:0006407 | rRNA export from nucleus(GO:0006407) |
0.0 | 0.0 | GO:0009996 | negative regulation of cell fate specification(GO:0009996) |
0.0 | 0.1 | GO:0060279 | positive regulation of ovulation(GO:0060279) |
0.0 | 0.2 | GO:0001778 | plasma membrane repair(GO:0001778) |
0.0 | 0.1 | GO:0035795 | negative regulation of mitochondrial membrane permeability(GO:0035795) |
0.0 | 0.2 | GO:0070525 | tRNA threonylcarbamoyladenosine metabolic process(GO:0070525) |
0.0 | 0.1 | GO:0035385 | Roundabout signaling pathway(GO:0035385) |
0.0 | 0.1 | GO:2000271 | positive regulation of fibroblast apoptotic process(GO:2000271) |
0.0 | 0.0 | GO:0072566 | chemokine (C-X-C motif) ligand 1 production(GO:0072566) regulation of chemokine (C-X-C motif) ligand 1 production(GO:2000338) |
0.0 | 0.1 | GO:0042363 | vitamin catabolic process(GO:0009111) fat-soluble vitamin catabolic process(GO:0042363) |
0.0 | 0.1 | GO:1902101 | positive regulation of mitotic metaphase/anaphase transition(GO:0045842) positive regulation of metaphase/anaphase transition of cell cycle(GO:1902101) |
0.0 | 0.1 | GO:1901299 | negative regulation of hydrogen peroxide-mediated programmed cell death(GO:1901299) |
0.0 | 0.2 | GO:0008216 | spermidine metabolic process(GO:0008216) |
0.0 | 0.3 | GO:1990126 | retrograde transport, endosome to plasma membrane(GO:1990126) |
0.0 | 0.5 | GO:0008053 | mitochondrial fusion(GO:0008053) |
0.0 | 0.1 | GO:0030576 | Cajal body organization(GO:0030576) |
0.0 | 0.1 | GO:0061635 | regulation of protein complex stability(GO:0061635) |
0.0 | 0.1 | GO:0071139 | resolution of recombination intermediates(GO:0071139) |
0.0 | 0.1 | GO:0071051 | polyadenylation-dependent snoRNA 3'-end processing(GO:0071051) |
0.0 | 0.0 | GO:1904528 | regulation of microtubule binding(GO:1904526) positive regulation of microtubule binding(GO:1904528) |
0.0 | 0.1 | GO:0002225 | positive regulation of antimicrobial peptide production(GO:0002225) positive regulation of antibacterial peptide production(GO:0002803) |
0.0 | 0.1 | GO:0015824 | proline transport(GO:0015824) |
0.0 | 0.1 | GO:0046135 | pyrimidine nucleoside catabolic process(GO:0046135) |
0.0 | 0.0 | GO:0060596 | mammary placode formation(GO:0060596) |
0.0 | 0.1 | GO:0033566 | gamma-tubulin complex localization(GO:0033566) |
0.0 | 0.3 | GO:0071242 | cellular response to ammonium ion(GO:0071242) |
0.0 | 0.1 | GO:0021889 | olfactory bulb interneuron differentiation(GO:0021889) |
0.0 | 0.1 | GO:0000055 | ribosomal large subunit export from nucleus(GO:0000055) |
0.0 | 0.0 | GO:0098868 | bone growth(GO:0098868) |
0.0 | 0.0 | GO:0061370 | testosterone biosynthetic process(GO:0061370) |
0.0 | 0.0 | GO:0060460 | left lung morphogenesis(GO:0060460) |
0.0 | 0.1 | GO:0032927 | positive regulation of activin receptor signaling pathway(GO:0032927) |
0.0 | 0.1 | GO:1903054 | negative regulation of extracellular matrix organization(GO:1903054) |
0.0 | 0.1 | GO:0009886 | post-embryonic morphogenesis(GO:0009886) |
0.0 | 0.1 | GO:0010820 | positive regulation of T cell chemotaxis(GO:0010820) |
0.0 | 0.0 | GO:1902093 | positive regulation of sperm motility(GO:1902093) |
0.0 | 0.3 | GO:0043567 | regulation of insulin-like growth factor receptor signaling pathway(GO:0043567) |
0.0 | 0.1 | GO:0000056 | ribosomal small subunit export from nucleus(GO:0000056) |
0.0 | 0.1 | GO:0045879 | negative regulation of smoothened signaling pathway(GO:0045879) |
0.0 | 0.0 | GO:1902083 | negative regulation of peptidyl-cysteine S-nitrosylation(GO:1902083) |
0.0 | 0.0 | GO:0070093 | negative regulation of glucagon secretion(GO:0070093) |
0.0 | 1.6 | GO:0007626 | locomotory behavior(GO:0007626) |
0.0 | 0.1 | GO:0021532 | neural tube patterning(GO:0021532) |
0.0 | 0.1 | GO:0042474 | middle ear morphogenesis(GO:0042474) |
0.0 | 0.0 | GO:1901491 | negative regulation of lymphangiogenesis(GO:1901491) |
0.0 | 0.2 | GO:0006957 | complement activation, alternative pathway(GO:0006957) |
0.0 | 0.2 | GO:0001833 | inner cell mass cell proliferation(GO:0001833) |
0.0 | 0.0 | GO:0007632 | visual behavior(GO:0007632) |
0.0 | 0.0 | GO:1904180 | negative regulation of membrane depolarization(GO:1904180) |
0.0 | 0.0 | GO:0048539 | bone marrow development(GO:0048539) |
0.0 | 0.1 | GO:0042574 | retinal metabolic process(GO:0042574) |
0.0 | 0.0 | GO:0051342 | regulation of cyclic-nucleotide phosphodiesterase activity(GO:0051342) negative regulation of cyclic-nucleotide phosphodiesterase activity(GO:0051344) |
0.0 | 0.0 | GO:0030397 | membrane disassembly(GO:0030397) nuclear envelope disassembly(GO:0051081) |
0.0 | 0.1 | GO:0002669 | positive regulation of T cell anergy(GO:0002669) positive regulation of lymphocyte anergy(GO:0002913) |
0.0 | 0.0 | GO:0050951 | sensory perception of temperature stimulus(GO:0050951) |
0.0 | 0.1 | GO:0010025 | wax biosynthetic process(GO:0010025) wax metabolic process(GO:0010166) |
0.0 | 0.2 | GO:1902175 | regulation of oxidative stress-induced intrinsic apoptotic signaling pathway(GO:1902175) |
0.0 | 0.1 | GO:0034983 | peptidyl-lysine deacetylation(GO:0034983) |
0.0 | 0.0 | GO:1900368 | regulation of RNA interference(GO:1900368) |
0.0 | 0.1 | GO:0000712 | resolution of meiotic recombination intermediates(GO:0000712) |
0.0 | 0.0 | GO:1902563 | regulation of neutrophil activation(GO:1902563) negative regulation of neutrophil activation(GO:1902564) regulation of eosinophil activation(GO:1902566) |
0.0 | 0.1 | GO:0006054 | N-acetylneuraminate metabolic process(GO:0006054) |
0.0 | 0.1 | GO:0060267 | positive regulation of respiratory burst(GO:0060267) |
0.0 | 0.1 | GO:0043988 | histone H3-S28 phosphorylation(GO:0043988) |
0.0 | 0.1 | GO:0051703 | social behavior(GO:0035176) intraspecies interaction between organisms(GO:0051703) |
0.0 | 0.0 | GO:0032741 | positive regulation of interleukin-18 production(GO:0032741) |
0.0 | 0.0 | GO:0007042 | lysosomal lumen acidification(GO:0007042) |
0.0 | 0.1 | GO:0007028 | cytoplasm organization(GO:0007028) |
0.0 | 0.0 | GO:0010255 | carbohydrate mediated signaling(GO:0009756) hexose mediated signaling(GO:0009757) sugar mediated signaling pathway(GO:0010182) glucose mediated signaling pathway(GO:0010255) |
0.0 | 0.1 | GO:1900037 | regulation of cellular response to hypoxia(GO:1900037) |
0.0 | 0.1 | GO:0006670 | sphingosine metabolic process(GO:0006670) |
0.0 | 0.0 | GO:0071043 | CUT catabolic process(GO:0071034) CUT metabolic process(GO:0071043) |
0.0 | 0.1 | GO:0046726 | positive regulation by virus of viral protein levels in host cell(GO:0046726) |
0.0 | 0.0 | GO:0072603 | interleukin-5 secretion(GO:0072603) interleukin-13 secretion(GO:0072611) regulation of interleukin-5 secretion(GO:2000662) regulation of interleukin-13 secretion(GO:2000665) |
0.0 | 0.1 | GO:0016338 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules(GO:0016338) |
0.0 | 0.1 | GO:0006689 | ganglioside catabolic process(GO:0006689) |
0.0 | 0.0 | GO:1903899 | positive regulation of PERK-mediated unfolded protein response(GO:1903899) |
0.0 | 0.1 | GO:0051923 | sulfation(GO:0051923) |
0.0 | 0.0 | GO:0097105 | presynaptic membrane assembly(GO:0097105) |
0.0 | 0.0 | GO:0051639 | actin filament network formation(GO:0051639) |
0.0 | 0.0 | GO:0021794 | thalamus development(GO:0021794) |
0.0 | 0.0 | GO:0002098 | tRNA wobble uridine modification(GO:0002098) |
0.0 | 0.0 | GO:0018195 | peptidyl-arginine modification(GO:0018195) |
0.0 | 0.0 | GO:0035435 | phosphate ion transmembrane transport(GO:0035435) |
0.0 | 0.0 | GO:0045760 | positive regulation of action potential(GO:0045760) |
0.0 | 0.1 | GO:0006561 | proline biosynthetic process(GO:0006561) |
0.0 | 0.0 | GO:0086016 | AV node cell action potential(GO:0086016) AV node cell to bundle of His cell signaling(GO:0086027) AV node cell to bundle of His cell communication(GO:0086067) |
0.0 | 0.0 | GO:0002434 | immune complex clearance(GO:0002434) |
0.0 | 0.0 | GO:0021988 | olfactory lobe development(GO:0021988) |
0.0 | 0.0 | GO:0071639 | positive regulation of monocyte chemotactic protein-1 production(GO:0071639) |
0.0 | 0.1 | GO:0007617 | mating behavior(GO:0007617) multi-organism reproductive behavior(GO:0044705) |
0.0 | 0.0 | GO:0032672 | regulation of interleukin-3 production(GO:0032672) |
0.0 | 0.3 | GO:0043252 | sodium-independent organic anion transport(GO:0043252) |
0.0 | 0.0 | GO:0006285 | base-excision repair, AP site formation(GO:0006285) |
0.0 | 0.0 | GO:0090191 | negative regulation of branching involved in ureteric bud morphogenesis(GO:0090191) |
0.0 | 0.0 | GO:0002925 | positive regulation of humoral immune response mediated by circulating immunoglobulin(GO:0002925) |
0.0 | 0.1 | GO:0034389 | lipid particle organization(GO:0034389) |
0.0 | 0.0 | GO:0038095 | Fc-epsilon receptor signaling pathway(GO:0038095) |
0.0 | 0.0 | GO:0009181 | purine nucleoside diphosphate catabolic process(GO:0009137) purine ribonucleoside diphosphate catabolic process(GO:0009181) |
0.0 | 0.0 | GO:0032714 | negative regulation of interleukin-5 production(GO:0032714) |
0.0 | 0.0 | GO:0055064 | chloride ion homeostasis(GO:0055064) |
0.0 | 0.1 | GO:0032401 | establishment of melanosome localization(GO:0032401) |
0.0 | 0.0 | GO:0000052 | citrulline metabolic process(GO:0000052) |
0.0 | 0.3 | GO:0035036 | sperm-egg recognition(GO:0035036) |
0.0 | 0.0 | GO:0052405 | negative regulation by host of symbiont molecular function(GO:0052405) modification by host of symbiont molecular function(GO:0052428) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.8 | 2.4 | GO:0016533 | cyclin-dependent protein kinase 5 holoenzyme complex(GO:0016533) |
0.8 | 9.4 | GO:0017146 | NMDA selective glutamate receptor complex(GO:0017146) |
0.8 | 2.3 | GO:0097427 | microtubule bundle(GO:0097427) |
0.7 | 4.4 | GO:0019907 | cyclin-dependent protein kinase activating kinase holoenzyme complex(GO:0019907) |
0.7 | 2.1 | GO:0038037 | G-protein coupled receptor dimeric complex(GO:0038037) G-protein coupled receptor complex(GO:0097648) |
0.7 | 4.1 | GO:0031258 | lamellipodium membrane(GO:0031258) |
0.7 | 6.0 | GO:0005883 | neurofilament(GO:0005883) |
0.7 | 6.6 | GO:0044224 | juxtaparanode region of axon(GO:0044224) |
0.6 | 2.6 | GO:0030868 | smooth endoplasmic reticulum membrane(GO:0030868) smooth endoplasmic reticulum part(GO:0097425) |
0.6 | 4.1 | GO:0098563 | integral component of synaptic vesicle membrane(GO:0030285) intrinsic component of synaptic vesicle membrane(GO:0098563) |
0.5 | 2.1 | GO:0070033 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin II complex(GO:0070033) |
0.5 | 9.5 | GO:0060077 | inhibitory synapse(GO:0060077) |
0.5 | 1.5 | GO:0005594 | collagen type IX trimer(GO:0005594) |
0.5 | 0.9 | GO:0046691 | intracellular canaliculus(GO:0046691) |
0.5 | 1.8 | GO:0042583 | chromaffin granule(GO:0042583) |
0.4 | 2.2 | GO:0043083 | synaptic cleft(GO:0043083) |
0.4 | 3.6 | GO:0042788 | polysomal ribosome(GO:0042788) |
0.4 | 2.8 | GO:0032584 | growth cone membrane(GO:0032584) |
0.4 | 11.4 | GO:0032281 | AMPA glutamate receptor complex(GO:0032281) |
0.4 | 1.9 | GO:0097255 | R2TP complex(GO:0097255) |
0.4 | 0.4 | GO:0070032 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin I complex(GO:0070032) |
0.4 | 1.5 | GO:0032983 | kainate selective glutamate receptor complex(GO:0032983) |
0.4 | 1.9 | GO:0043203 | axon hillock(GO:0043203) |
0.4 | 3.7 | GO:0030673 | axolemma(GO:0030673) |
0.3 | 1.9 | GO:0001674 | female germ cell nucleus(GO:0001674) |
0.3 | 0.6 | GO:1990761 | growth cone lamellipodium(GO:1990761) |
0.3 | 1.2 | GO:0044326 | dendritic spine neck(GO:0044326) |
0.3 | 3.6 | GO:0043194 | axon initial segment(GO:0043194) |
0.3 | 12.4 | GO:0042734 | presynaptic membrane(GO:0042734) |
0.3 | 1.1 | GO:0061574 | ASAP complex(GO:0061574) |
0.3 | 0.8 | GO:0044308 | axonal spine(GO:0044308) |
0.3 | 2.5 | GO:0035253 | ciliary rootlet(GO:0035253) |
0.3 | 0.3 | GO:0031618 | nuclear pericentric heterochromatin(GO:0031618) |
0.3 | 0.8 | GO:0070552 | BRISC complex(GO:0070552) |
0.3 | 0.8 | GO:0033268 | node of Ranvier(GO:0033268) |
0.3 | 1.9 | GO:0036057 | filtration diaphragm(GO:0036056) slit diaphragm(GO:0036057) |
0.3 | 2.1 | GO:0005677 | chromatin silencing complex(GO:0005677) |
0.2 | 1.0 | GO:1990696 | USH2 complex(GO:1990696) |
0.2 | 3.2 | GO:0043196 | varicosity(GO:0043196) |
0.2 | 1.0 | GO:0042567 | insulin-like growth factor binding protein complex(GO:0016942) growth factor complex(GO:0036454) insulin-like growth factor ternary complex(GO:0042567) |
0.2 | 0.7 | GO:0014701 | junctional sarcoplasmic reticulum membrane(GO:0014701) |
0.2 | 5.3 | GO:0044295 | axonal growth cone(GO:0044295) |
0.2 | 1.0 | GO:1990851 | Wnt-Frizzled-LRP5/6 complex(GO:1990851) |
0.2 | 0.7 | GO:0008091 | spectrin(GO:0008091) |
0.2 | 2.8 | GO:0098643 | fibrillar collagen trimer(GO:0005583) banded collagen fibril(GO:0098643) |
0.2 | 6.6 | GO:0099501 | synaptic vesicle membrane(GO:0030672) exocytic vesicle membrane(GO:0099501) |
0.2 | 1.6 | GO:0008290 | F-actin capping protein complex(GO:0008290) |
0.2 | 2.5 | GO:0035102 | PRC1 complex(GO:0035102) |
0.2 | 2.1 | GO:0030061 | mitochondrial crista(GO:0030061) |
0.2 | 0.7 | GO:0072534 | perineuronal net(GO:0072534) |
0.2 | 2.8 | GO:0034706 | sodium channel complex(GO:0034706) |
0.2 | 1.7 | GO:0071437 | invadopodium(GO:0071437) |
0.2 | 1.3 | GO:0098553 | integral component of cytoplasmic side of endoplasmic reticulum membrane(GO:0071458) integral component of lumenal side of endoplasmic reticulum membrane(GO:0071556) lumenal side of endoplasmic reticulum membrane(GO:0098553) |
0.2 | 0.6 | GO:0055087 | Ski complex(GO:0055087) |
0.2 | 0.2 | GO:0031088 | platelet dense granule membrane(GO:0031088) |
0.2 | 4.3 | GO:0032589 | neuron projection membrane(GO:0032589) |
0.2 | 1.6 | GO:0097449 | astrocyte projection(GO:0097449) |
0.2 | 0.2 | GO:0008328 | ionotropic glutamate receptor complex(GO:0008328) neurotransmitter receptor complex(GO:0098878) |
0.2 | 5.8 | GO:0005891 | voltage-gated calcium channel complex(GO:0005891) |
0.2 | 0.9 | GO:0097060 | synaptic membrane(GO:0097060) |
0.2 | 2.0 | GO:0032433 | filopodium tip(GO:0032433) |
0.2 | 0.5 | GO:0090498 | extrinsic component of Golgi membrane(GO:0090498) |
0.2 | 0.5 | GO:1990907 | beta-catenin-TCF complex(GO:1990907) |
0.2 | 25.8 | GO:0045211 | postsynaptic membrane(GO:0045211) |
0.2 | 0.9 | GO:0071547 | piP-body(GO:0071547) |
0.2 | 0.9 | GO:0031428 | box C/D snoRNP complex(GO:0031428) |
0.2 | 3.3 | GO:0090545 | NuRD complex(GO:0016581) CHD-type complex(GO:0090545) |
0.2 | 1.3 | GO:0043020 | NADPH oxidase complex(GO:0043020) |
0.2 | 0.5 | GO:0036194 | muscle cell projection(GO:0036194) muscle cell projection membrane(GO:0036195) |
0.2 | 0.5 | GO:0070110 | ciliary neurotrophic factor receptor complex(GO:0070110) |
0.2 | 0.9 | GO:0031527 | filopodium membrane(GO:0031527) |
0.2 | 1.1 | GO:0005688 | U6 snRNP(GO:0005688) |
0.2 | 0.8 | GO:0044613 | nuclear pore central transport channel(GO:0044613) |
0.1 | 1.3 | GO:0002116 | semaphorin receptor complex(GO:0002116) |
0.1 | 3.2 | GO:0034451 | centriolar satellite(GO:0034451) |
0.1 | 1.8 | GO:0044298 | neuronal cell body membrane(GO:0032809) cell body membrane(GO:0044298) |
0.1 | 1.1 | GO:0031045 | dense core granule(GO:0031045) |
0.1 | 0.5 | GO:0089717 | spanning component of plasma membrane(GO:0044214) spanning component of membrane(GO:0089717) |
0.1 | 0.1 | GO:0042827 | platelet dense granule(GO:0042827) |
0.1 | 3.2 | GO:0043198 | dendritic shaft(GO:0043198) |
0.1 | 1.3 | GO:0030877 | beta-catenin destruction complex(GO:0030877) |
0.1 | 1.6 | GO:0043240 | Fanconi anaemia nuclear complex(GO:0043240) |
0.1 | 9.5 | GO:0043204 | perikaryon(GO:0043204) |
0.1 | 6.1 | GO:0008076 | voltage-gated potassium channel complex(GO:0008076) |
0.1 | 0.6 | GO:0034388 | Pwp2p-containing subcomplex of 90S preribosome(GO:0034388) |
0.1 | 0.4 | GO:0005606 | laminin-1 complex(GO:0005606) |
0.1 | 0.7 | GO:0005796 | Golgi lumen(GO:0005796) |
0.1 | 0.8 | GO:0000788 | nuclear nucleosome(GO:0000788) |
0.1 | 1.6 | GO:0071565 | nBAF complex(GO:0071565) |
0.1 | 0.2 | GO:0032437 | cuticular plate(GO:0032437) |
0.1 | 0.5 | GO:0032839 | dendrite cytoplasm(GO:0032839) |
0.1 | 0.3 | GO:1990909 | Wnt signalosome(GO:1990909) |
0.1 | 0.3 | GO:0031233 | intrinsic component of external side of plasma membrane(GO:0031233) |
0.1 | 0.3 | GO:0002193 | MAML1-RBP-Jkappa- ICN1 complex(GO:0002193) |
0.1 | 0.1 | GO:0005593 | FACIT collagen trimer(GO:0005593) |
0.1 | 0.4 | GO:0044530 | supraspliceosomal complex(GO:0044530) |
0.1 | 0.3 | GO:1990393 | 3M complex(GO:1990393) |
0.1 | 0.3 | GO:0036396 | MIS complex(GO:0036396) |
0.1 | 0.2 | GO:0035748 | myelin sheath abaxonal region(GO:0035748) |
0.1 | 0.3 | GO:0020018 | ciliary pocket(GO:0020016) ciliary pocket membrane(GO:0020018) |
0.1 | 0.3 | GO:0030121 | AP-1 adaptor complex(GO:0030121) |
0.1 | 0.3 | GO:0030289 | protein phosphatase 4 complex(GO:0030289) |
0.1 | 0.2 | GO:0005850 | eukaryotic translation initiation factor 2 complex(GO:0005850) |
0.1 | 0.2 | GO:0044462 | cell outer membrane(GO:0009279) cell envelope(GO:0030313) external encapsulating structure part(GO:0044462) |
0.1 | 1.6 | GO:0032588 | trans-Golgi network membrane(GO:0032588) |
0.1 | 2.4 | GO:0016235 | aggresome(GO:0016235) |
0.1 | 0.4 | GO:0032021 | NELF complex(GO:0032021) |
0.1 | 3.2 | GO:0005834 | heterotrimeric G-protein complex(GO:0005834) |
0.1 | 0.1 | GO:0071598 | neuronal ribonucleoprotein granule(GO:0071598) |
0.1 | 0.2 | GO:0017071 | intracellular cyclic nucleotide activated cation channel complex(GO:0017071) |
0.1 | 0.3 | GO:0005818 | astral microtubule(GO:0000235) aster(GO:0005818) |
0.1 | 5.7 | GO:0030426 | growth cone(GO:0030426) |
0.1 | 1.1 | GO:0032580 | Golgi cisterna membrane(GO:0032580) |
0.1 | 0.3 | GO:0031315 | extrinsic component of mitochondrial outer membrane(GO:0031315) |
0.1 | 0.2 | GO:0000835 | ER ubiquitin ligase complex(GO:0000835) Hrd1p ubiquitin ligase complex(GO:0000836) |
0.1 | 0.3 | GO:0061689 | tricellular tight junction(GO:0061689) |
0.1 | 0.2 | GO:0097524 | sperm plasma membrane(GO:0097524) |
0.1 | 0.2 | GO:0043527 | tRNA methyltransferase complex(GO:0043527) |
0.1 | 0.3 | GO:0098536 | deuterosome(GO:0098536) |
0.1 | 0.3 | GO:0043202 | lysosomal lumen(GO:0043202) |
0.1 | 0.2 | GO:0032585 | multivesicular body membrane(GO:0032585) |
0.1 | 1.1 | GO:0005665 | DNA-directed RNA polymerase II, core complex(GO:0005665) |
0.1 | 0.6 | GO:0000243 | commitment complex(GO:0000243) |
0.1 | 0.2 | GO:0045098 | type III intermediate filament(GO:0045098) |
0.1 | 0.2 | GO:0097149 | centralspindlin complex(GO:0097149) |
0.1 | 0.6 | GO:0036156 | inner dynein arm(GO:0036156) |
0.1 | 9.7 | GO:0031225 | anchored component of membrane(GO:0031225) |
0.1 | 0.8 | GO:0005790 | smooth endoplasmic reticulum(GO:0005790) |
0.1 | 0.2 | GO:0071818 | BAT3 complex(GO:0071818) ER membrane insertion complex(GO:0072379) |
0.1 | 0.2 | GO:0016222 | procollagen-proline 4-dioxygenase complex(GO:0016222) |
0.1 | 0.3 | GO:0042824 | MHC class I peptide loading complex(GO:0042824) |
0.1 | 0.3 | GO:0019815 | B cell receptor complex(GO:0019815) |
0.1 | 0.1 | GO:0016514 | SWI/SNF complex(GO:0016514) |
0.1 | 0.1 | GO:0044393 | microspike(GO:0044393) |
0.1 | 0.4 | GO:0034366 | spherical high-density lipoprotein particle(GO:0034366) |
0.1 | 0.2 | GO:0000322 | storage vacuole(GO:0000322) |
0.1 | 4.3 | GO:0043679 | axon terminus(GO:0043679) |
0.1 | 0.3 | GO:0005638 | lamin filament(GO:0005638) |
0.1 | 2.3 | GO:0045095 | keratin filament(GO:0045095) |
0.1 | 0.1 | GO:0035985 | senescence-associated heterochromatin focus(GO:0035985) |
0.1 | 0.3 | GO:0042765 | GPI-anchor transamidase complex(GO:0042765) |
0.1 | 0.1 | GO:0097169 | AIM2 inflammasome complex(GO:0097169) |
0.1 | 0.2 | GO:0000110 | nucleotide-excision repair factor 1 complex(GO:0000110) |
0.1 | 1.2 | GO:0030175 | filopodium(GO:0030175) |
0.1 | 0.2 | GO:0032444 | activin responsive factor complex(GO:0032444) |
0.1 | 0.7 | GO:0001741 | XY body(GO:0001741) |
0.1 | 0.3 | GO:0071439 | clathrin complex(GO:0071439) |
0.0 | 0.2 | GO:1990716 | axonemal central apparatus(GO:1990716) |
0.0 | 0.1 | GO:0097629 | extrinsic component of omegasome membrane(GO:0097629) |
0.0 | 0.4 | GO:0097225 | sperm midpiece(GO:0097225) |
0.0 | 0.1 | GO:0044300 | cerebellar mossy fiber(GO:0044300) |
0.0 | 0.2 | GO:0030015 | CCR4-NOT core complex(GO:0030015) |
0.0 | 0.3 | GO:0044306 | neuron projection terminus(GO:0044306) |
0.0 | 0.3 | GO:0070578 | RISC-loading complex(GO:0070578) |
0.0 | 0.1 | GO:0016939 | kinesin II complex(GO:0016939) |
0.0 | 0.3 | GO:0034992 | microtubule organizing center attachment site(GO:0034992) LINC complex(GO:0034993) |
0.0 | 0.4 | GO:0048188 | Set1C/COMPASS complex(GO:0048188) |
0.0 | 0.1 | GO:0070852 | cell body fiber(GO:0070852) |
0.0 | 2.2 | GO:0031526 | brush border membrane(GO:0031526) |
0.0 | 0.4 | GO:0000782 | telomere cap complex(GO:0000782) nuclear telomere cap complex(GO:0000783) |
0.0 | 0.1 | GO:0071001 | U4/U6 snRNP(GO:0071001) |
0.0 | 1.5 | GO:0017053 | transcriptional repressor complex(GO:0017053) |
0.0 | 0.1 | GO:0000811 | GINS complex(GO:0000811) |
0.0 | 0.3 | GO:0000137 | Golgi cis cisterna(GO:0000137) |
0.0 | 0.2 | GO:0000812 | Swr1 complex(GO:0000812) |
0.0 | 0.1 | GO:0043511 | inhibin complex(GO:0043511) |
0.0 | 0.3 | GO:0019773 | proteasome core complex, alpha-subunit complex(GO:0019773) |
0.0 | 0.1 | GO:0032937 | SREBP-SCAP-Insig complex(GO:0032937) |
0.0 | 1.3 | GO:0008021 | synaptic vesicle(GO:0008021) |
0.0 | 0.1 | GO:0005745 | m-AAA complex(GO:0005745) |
0.0 | 0.2 | GO:0000791 | euchromatin(GO:0000791) |
0.0 | 0.4 | GO:0010369 | chromocenter(GO:0010369) |
0.0 | 0.6 | GO:0005719 | nuclear euchromatin(GO:0005719) |
0.0 | 0.4 | GO:0005847 | mRNA cleavage and polyadenylation specificity factor complex(GO:0005847) |
0.0 | 0.1 | GO:0000408 | EKC/KEOPS complex(GO:0000408) |
0.0 | 7.6 | GO:0043025 | neuronal cell body(GO:0043025) |
0.0 | 0.4 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
0.0 | 0.1 | GO:0032806 | carboxy-terminal domain protein kinase complex(GO:0032806) |
0.0 | 0.1 | GO:0033503 | HULC complex(GO:0033503) |
0.0 | 0.0 | GO:0000125 | PCAF complex(GO:0000125) |
0.0 | 0.1 | GO:0071546 | pi-body(GO:0071546) |
0.0 | 0.1 | GO:0005851 | eukaryotic translation initiation factor 2B complex(GO:0005851) |
0.0 | 0.1 | GO:0033588 | Elongator holoenzyme complex(GO:0033588) |
0.0 | 0.1 | GO:0002189 | ribose phosphate diphosphokinase complex(GO:0002189) |
0.0 | 0.1 | GO:0045179 | apical cortex(GO:0045179) |
0.0 | 0.8 | GO:0005921 | gap junction(GO:0005921) |
0.0 | 0.2 | GO:0036157 | outer dynein arm(GO:0036157) |
0.0 | 0.3 | GO:0031616 | spindle pole centrosome(GO:0031616) |
0.0 | 0.5 | GO:0030904 | retromer complex(GO:0030904) |
0.0 | 0.1 | GO:0033185 | dolichol-phosphate-mannose synthase complex(GO:0033185) |
0.0 | 0.1 | GO:0000275 | mitochondrial proton-transporting ATP synthase complex, catalytic core F(1)(GO:0000275) proton-transporting ATP synthase complex, catalytic core F(1)(GO:0045261) |
0.0 | 7.5 | GO:0005667 | transcription factor complex(GO:0005667) |
0.0 | 0.1 | GO:0034715 | pICln-Sm protein complex(GO:0034715) |
0.0 | 0.3 | GO:0030131 | clathrin adaptor complex(GO:0030131) |
0.0 | 0.0 | GO:0030670 | phagocytic vesicle membrane(GO:0030670) |
0.0 | 0.1 | GO:1990745 | EARP complex(GO:1990745) |
0.0 | 0.1 | GO:0000802 | transverse filament(GO:0000802) |
0.0 | 2.0 | GO:0035068 | micro-ribonucleoprotein complex(GO:0035068) |
0.0 | 0.1 | GO:0031314 | extrinsic component of mitochondrial inner membrane(GO:0031314) |
0.0 | 0.0 | GO:0070531 | BRCA1-A complex(GO:0070531) |
0.0 | 0.0 | GO:1902710 | GABA receptor complex(GO:1902710) GABA-A receptor complex(GO:1902711) |
0.0 | 0.1 | GO:0002079 | inner acrosomal membrane(GO:0002079) |
0.0 | 0.1 | GO:0042571 | immunoglobulin complex, circulating(GO:0042571) |
0.0 | 0.0 | GO:0005853 | eukaryotic translation elongation factor 1 complex(GO:0005853) |
0.0 | 0.4 | GO:0045335 | phagocytic vesicle(GO:0045335) |
0.0 | 0.0 | GO:0030128 | clathrin coat of endocytic vesicle(GO:0030128) |
0.0 | 0.1 | GO:0005845 | mRNA cap binding complex(GO:0005845) RNA cap binding complex(GO:0034518) |
0.0 | 0.0 | GO:0016589 | NURF complex(GO:0016589) |
0.0 | 2.6 | GO:0043005 | neuron projection(GO:0043005) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.1 | 3.3 | GO:0097109 | neuroligin family protein binding(GO:0097109) |
1.1 | 5.4 | GO:0015277 | kainate selective glutamate receptor activity(GO:0015277) |
1.0 | 4.8 | GO:0044323 | retinoic acid-responsive element binding(GO:0044323) |
0.9 | 4.4 | GO:0015185 | gamma-aminobutyric acid transmembrane transporter activity(GO:0015185) |
0.9 | 0.9 | GO:0015141 | succinate transmembrane transporter activity(GO:0015141) |
0.9 | 4.3 | GO:0003828 | alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity(GO:0003828) |
0.8 | 2.5 | GO:0030160 | GKAP/Homer scaffold activity(GO:0030160) |
0.8 | 4.9 | GO:0005005 | transmembrane-ephrin receptor activity(GO:0005005) |
0.8 | 2.4 | GO:0046976 | histone methyltransferase activity (H3-K27 specific)(GO:0046976) |
0.8 | 3.2 | GO:0005042 | netrin receptor activity(GO:0005042) |
0.7 | 2.2 | GO:0008401 | retinoic acid 4-hydroxylase activity(GO:0008401) |
0.7 | 5.7 | GO:0004972 | NMDA glutamate receptor activity(GO:0004972) |
0.7 | 4.0 | GO:0016933 | extracellular-glycine-gated ion channel activity(GO:0016933) extracellular-glycine-gated chloride channel activity(GO:0016934) |
0.6 | 5.2 | GO:0098988 | G-protein coupled glutamate receptor activity(GO:0098988) |
0.6 | 4.5 | GO:0003680 | AT DNA binding(GO:0003680) |
0.6 | 1.9 | GO:0004351 | glutamate decarboxylase activity(GO:0004351) |
0.6 | 1.8 | GO:0005519 | cytoskeletal regulatory protein binding(GO:0005519) |
0.5 | 7.0 | GO:0000983 | transcription factor activity, RNA polymerase II core promoter sequence-specific(GO:0000983) |
0.5 | 0.5 | GO:0034056 | estrogen response element binding(GO:0034056) |
0.5 | 2.6 | GO:0086080 | protein binding involved in heterotypic cell-cell adhesion(GO:0086080) |
0.5 | 2.6 | GO:0000155 | phosphorelay sensor kinase activity(GO:0000155) |
0.5 | 3.9 | GO:0016175 | superoxide-generating NADPH oxidase activity(GO:0016175) |
0.5 | 0.5 | GO:0005237 | inhibitory extracellular ligand-gated ion channel activity(GO:0005237) |
0.5 | 6.0 | GO:0048018 | receptor agonist activity(GO:0048018) |
0.5 | 1.4 | GO:0008332 | low voltage-gated calcium channel activity(GO:0008332) |
0.5 | 0.9 | GO:0004886 | 9-cis retinoic acid receptor activity(GO:0004886) |
0.4 | 1.7 | GO:0046870 | cadmium ion binding(GO:0046870) |
0.4 | 3.0 | GO:0015280 | ligand-gated sodium channel activity(GO:0015280) |
0.4 | 1.7 | GO:0032051 | clathrin light chain binding(GO:0032051) |
0.4 | 2.6 | GO:0048495 | Roundabout binding(GO:0048495) |
0.4 | 1.3 | GO:0015018 | galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity(GO:0015018) |
0.4 | 2.0 | GO:0004111 | creatine kinase activity(GO:0004111) |
0.4 | 0.8 | GO:0070644 | vitamin D response element binding(GO:0070644) |
0.4 | 1.2 | GO:0034739 | histone deacetylase activity (H4-K16 specific)(GO:0034739) |
0.4 | 0.8 | GO:0031697 | beta-1 adrenergic receptor binding(GO:0031697) |
0.4 | 1.2 | GO:0018575 | 2,3-dihydroxy DDT 1,2-dioxygenase activity(GO:0018542) phenanthrene dioxygenase activity(GO:0018555) 2,2',3-trihydroxybiphenyl dioxygenase activity(GO:0018556) 1,2-dihydroxyfluorene 1,1-alpha-dioxygenase activity(GO:0018557) 5,6-dihydroxy-3-methyl-2-oxo-1,2-dihydroquinoline dioxygenase activity(GO:0018558) 1,1-dichloro-2-(dihydroxy-4-chlorophenyl)-(4-chlorophenyl)ethene 1,2-dioxygenase activity(GO:0018559) protocatechuate 3,4-dioxygenase type II activity(GO:0018560) 2'-aminobiphenyl-2,3-diol 1,2-dioxygenase activity(GO:0018561) 3,4-dihydroxyfluorene 4,4-alpha-dioxygenase activity(GO:0018562) 2,3-dihydroxy-ethylbenzene 1,2-dioxygenase activity(GO:0018563) carbazole 1,9a-dioxygenase activity(GO:0018564) dihydroxydibenzothiophene dioxygenase activity(GO:0018565) 1,2-dihydroxynaphthalene-6-sulfonate 1,8a-dioxygenase activity(GO:0018566) styrene dioxygenase activity(GO:0018567) 3,4-dihydroxyphenanthrene dioxygenase activity(GO:0018568) hydroquinone 1,2-dioxygenase activity(GO:0018569) p-cumate 2,3-dioxygenase activity(GO:0018570) 2,3-dihydroxy-p-cumate dioxygenase activity(GO:0018571) 3,5-dichlorocatechol 1,2-dioxygenase activity(GO:0018572) 2-aminophenol 1,6-dioxygenase activity(GO:0018573) 2,6-dichloro-p-hydroquinone 1,2-dioxygenase activity(GO:0018574) chlorocatechol 1,2-dioxygenase activity(GO:0018575) catechol dioxygenase activity(GO:0019114) dihydroxyfluorene dioxygenase activity(GO:0019117) 5-aminosalicylate dioxygenase activity(GO:0034543) 3-hydroxy-2-naphthoate 2,3-dioxygenase activity(GO:0034803) benzo(a)pyrene 11,12-dioxygenase activity(GO:0034806) benzo(a)pyrene 4,5-dioxygenase activity(GO:0034808) 4,5-dihydroxybenzo(a)pyrene dioxygenase activity(GO:0034810) benzo(a)pyrene 9,10-dioxygenase activity(GO:0034811) 9,10-dihydroxybenzo(a)pyrene dioxygenase activity(GO:0034812) benzo(a)pyrene 7,8-dioxygenase activity(GO:0034813) 7,8-dihydroxy benzo(a)pyrene dioxygenase activity(GO:0034814) 1,2-dihydroxy-5,6,7,8-tetrahydronaphthalene extradiol dioxygenase activity(GO:0034827) 2-mercaptobenzothiazole dioxygenase activity(GO:0034834) pyridine-3,4-diol dioxygenase activity(GO:0034895) pyrene dioxygenase activity(GO:0034920) 4,5-dihydroxypyrene dioxygenase activity(GO:0034922) phenanthrene-4-carboxylate dioxygenase activity(GO:0034934) tetrachlorobenzene dioxygenase activity(GO:0034935) 4,6-dichloro-3-methylcatechol 1,2-dioxygenase activity(GO:0034936) 2,3-dihydroxydiphenyl ether dioxygenase activity(GO:0034955) diphenyl ether 1,2-dioxygenase activity(GO:0034956) arachidonate 8(S)-lipoxygenase activity(GO:0036403) 4-hydroxycatechol 1,2-dioxygenase activity(GO:0047074) |
0.4 | 0.4 | GO:0017098 | sulfonylurea receptor binding(GO:0017098) |
0.4 | 7.9 | GO:0071837 | HMG box domain binding(GO:0071837) |
0.4 | 1.1 | GO:0008475 | procollagen-lysine 5-dioxygenase activity(GO:0008475) |
0.4 | 1.1 | GO:0015137 | citrate transmembrane transporter activity(GO:0015137) tricarboxylic acid transmembrane transporter activity(GO:0015142) |
0.4 | 1.4 | GO:0035727 | lysophosphatidic acid binding(GO:0035727) |
0.3 | 1.7 | GO:0003958 | NADPH-hemoprotein reductase activity(GO:0003958) |
0.3 | 1.0 | GO:0005176 | ErbB-2 class receptor binding(GO:0005176) |
0.3 | 1.3 | GO:0005030 | neurotrophin receptor activity(GO:0005030) |
0.3 | 2.9 | GO:0001972 | retinoic acid binding(GO:0001972) |
0.3 | 0.9 | GO:0004999 | vasoactive intestinal polypeptide receptor activity(GO:0004999) |
0.3 | 1.3 | GO:0015375 | glycine:sodium symporter activity(GO:0015375) |
0.3 | 0.9 | GO:0008503 | benzodiazepine receptor activity(GO:0008503) |
0.3 | 1.6 | GO:0005007 | fibroblast growth factor-activated receptor activity(GO:0005007) |
0.3 | 0.6 | GO:0071532 | ankyrin repeat binding(GO:0071532) |
0.3 | 3.4 | GO:0008195 | phosphatidate phosphatase activity(GO:0008195) |
0.3 | 0.9 | GO:0051733 | ATP-dependent polydeoxyribonucleotide 5'-hydroxyl-kinase activity(GO:0046404) polydeoxyribonucleotide kinase activity(GO:0051733) |
0.3 | 0.6 | GO:0048101 | calcium- and calmodulin-regulated 3',5'-cyclic-GMP phosphodiesterase activity(GO:0048101) |
0.3 | 5.8 | GO:0017075 | syntaxin-1 binding(GO:0017075) |
0.3 | 2.0 | GO:0031995 | insulin-like growth factor II binding(GO:0031995) |
0.3 | 4.0 | GO:0045295 | gamma-catenin binding(GO:0045295) |
0.3 | 2.5 | GO:0001091 | RNA polymerase II basal transcription factor binding(GO:0001091) |
0.3 | 1.1 | GO:0005004 | GPI-linked ephrin receptor activity(GO:0005004) |
0.3 | 0.8 | GO:0004980 | melanocyte-stimulating hormone receptor activity(GO:0004980) |
0.3 | 0.3 | GO:0031750 | D3 dopamine receptor binding(GO:0031750) |
0.3 | 1.3 | GO:0008467 | [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity(GO:0008467) |
0.3 | 0.8 | GO:0004965 | G-protein coupled GABA receptor activity(GO:0004965) |
0.3 | 0.8 | GO:0035373 | chondroitin sulfate proteoglycan binding(GO:0035373) |
0.3 | 3.4 | GO:0035198 | miRNA binding(GO:0035198) |
0.3 | 0.8 | GO:0004995 | tachykinin receptor activity(GO:0004995) |
0.3 | 0.8 | GO:0000702 | oxidized base lesion DNA N-glycosylase activity(GO:0000702) |
0.3 | 0.8 | GO:0000309 | nicotinamide-nucleotide adenylyltransferase activity(GO:0000309) nicotinate-nucleotide adenylyltransferase activity(GO:0004515) |
0.3 | 2.9 | GO:0008331 | high voltage-gated calcium channel activity(GO:0008331) |
0.3 | 0.5 | GO:0035851 | Krueppel-associated box domain binding(GO:0035851) |
0.3 | 1.6 | GO:0004385 | guanylate kinase activity(GO:0004385) |
0.3 | 1.0 | GO:0004969 | histamine receptor activity(GO:0004969) |
0.3 | 1.5 | GO:0005225 | volume-sensitive anion channel activity(GO:0005225) |
0.2 | 1.0 | GO:0035241 | protein-arginine omega-N monomethyltransferase activity(GO:0035241) |
0.2 | 1.2 | GO:0004985 | opioid receptor activity(GO:0004985) |
0.2 | 1.0 | GO:0070579 | methylcytosine dioxygenase activity(GO:0070579) |
0.2 | 0.5 | GO:0046974 | histone methyltransferase activity (H3-K9 specific)(GO:0046974) |
0.2 | 0.7 | GO:0097108 | hedgehog family protein binding(GO:0097108) |
0.2 | 3.5 | GO:0030275 | LRR domain binding(GO:0030275) |
0.2 | 0.2 | GO:0001962 | alpha-1,3-galactosyltransferase activity(GO:0001962) |
0.2 | 4.3 | GO:0005248 | voltage-gated sodium channel activity(GO:0005248) voltage-gated ion channel activity involved in regulation of postsynaptic membrane potential(GO:1905030) |
0.2 | 0.7 | GO:0001591 | dopamine neurotransmitter receptor activity, coupled via Gi/Go(GO:0001591) |
0.2 | 0.2 | GO:0043125 | ErbB-3 class receptor binding(GO:0043125) |
0.2 | 0.9 | GO:0004966 | galanin receptor activity(GO:0004966) |
0.2 | 1.5 | GO:0005272 | sodium channel activity(GO:0005272) |
0.2 | 1.7 | GO:0005167 | neurotrophin TRK receptor binding(GO:0005167) |
0.2 | 0.9 | GO:0004528 | phosphodiesterase I activity(GO:0004528) |
0.2 | 0.9 | GO:0004952 | dopamine neurotransmitter receptor activity, coupled via Gs(GO:0001588) dopamine neurotransmitter receptor activity(GO:0004952) |
0.2 | 0.6 | GO:0004967 | glucagon receptor activity(GO:0004967) |
0.2 | 1.1 | GO:0031748 | D1 dopamine receptor binding(GO:0031748) |
0.2 | 0.6 | GO:0004793 | threonine aldolase activity(GO:0004793) L-allo-threonine aldolase activity(GO:0008732) |
0.2 | 0.6 | GO:0016647 | oxidoreductase activity, acting on the CH-NH group of donors, oxygen as acceptor(GO:0016647) |
0.2 | 1.0 | GO:0001515 | opioid peptide activity(GO:0001515) |
0.2 | 0.8 | GO:0015220 | choline transmembrane transporter activity(GO:0015220) |
0.2 | 0.6 | GO:0008073 | ornithine decarboxylase inhibitor activity(GO:0008073) |
0.2 | 1.7 | GO:0008889 | glycerophosphodiester phosphodiesterase activity(GO:0008889) |
0.2 | 0.8 | GO:0004035 | alkaline phosphatase activity(GO:0004035) |
0.2 | 0.6 | GO:1990715 | mRNA CDS binding(GO:1990715) |
0.2 | 1.6 | GO:0008599 | protein phosphatase type 1 regulator activity(GO:0008599) |
0.2 | 2.8 | GO:0022841 | potassium ion leak channel activity(GO:0022841) |
0.2 | 0.6 | GO:0051718 | DNA (cytosine-5-)-methyltransferase activity(GO:0003886) DNA (cytosine-5-)-methyltransferase activity, acting on CpG substrates(GO:0051718) |
0.2 | 1.0 | GO:0033130 | acetylcholine receptor binding(GO:0033130) |
0.2 | 0.2 | GO:0043855 | intracellular cyclic nucleotide activated cation channel activity(GO:0005221) cyclic nucleotide-gated ion channel activity(GO:0043855) |
0.2 | 4.3 | GO:0045499 | chemorepellent activity(GO:0045499) |
0.2 | 4.5 | GO:0017091 | AU-rich element binding(GO:0017091) |
0.2 | 0.6 | GO:0034190 | apolipoprotein receptor binding(GO:0034190) |
0.2 | 0.4 | GO:0004027 | alcohol sulfotransferase activity(GO:0004027) |
0.2 | 0.6 | GO:0005146 | leukemia inhibitory factor receptor binding(GO:0005146) |
0.2 | 0.6 | GO:0051430 | corticotropin-releasing hormone receptor 1 binding(GO:0051430) |
0.2 | 0.9 | GO:0035033 | histone deacetylase regulator activity(GO:0035033) |
0.2 | 0.5 | GO:0005283 | sodium:amino acid symporter activity(GO:0005283) |
0.2 | 2.3 | GO:0050811 | GABA receptor binding(GO:0050811) |
0.2 | 0.5 | GO:0003941 | L-serine ammonia-lyase activity(GO:0003941) |
0.2 | 0.2 | GO:0022842 | leak channel activity(GO:0022840) narrow pore channel activity(GO:0022842) |
0.2 | 0.2 | GO:0070698 | type I activin receptor binding(GO:0070698) |
0.2 | 2.4 | GO:0051428 | peptide hormone receptor binding(GO:0051428) |
0.2 | 2.2 | GO:0015643 | toxic substance binding(GO:0015643) |
0.2 | 0.3 | GO:0015143 | urate transmembrane transporter activity(GO:0015143) salt transmembrane transporter activity(GO:1901702) |
0.2 | 1.0 | GO:0030306 | ADP-ribosylation factor binding(GO:0030306) |
0.2 | 0.5 | GO:0050252 | retinol O-fatty-acyltransferase activity(GO:0050252) |
0.2 | 4.0 | GO:0005245 | voltage-gated calcium channel activity(GO:0005245) |
0.2 | 0.3 | GO:0019002 | GMP binding(GO:0019002) |
0.2 | 0.2 | GO:0038191 | neuropilin binding(GO:0038191) |
0.2 | 3.9 | GO:0005251 | delayed rectifier potassium channel activity(GO:0005251) |
0.2 | 1.5 | GO:0015168 | glycerol transmembrane transporter activity(GO:0015168) glycerol channel activity(GO:0015254) |
0.2 | 1.9 | GO:0031005 | filamin binding(GO:0031005) |
0.2 | 6.4 | GO:0034483 | heparan sulfate sulfotransferase activity(GO:0034483) |
0.2 | 1.3 | GO:0099602 | acetylcholine receptor regulator activity(GO:0030548) neurotransmitter receptor regulator activity(GO:0099602) |
0.2 | 1.6 | GO:0050321 | tau-protein kinase activity(GO:0050321) |
0.2 | 0.3 | GO:0015111 | iodide transmembrane transporter activity(GO:0015111) |
0.2 | 0.5 | GO:0008107 | galactoside 2-alpha-L-fucosyltransferase activity(GO:0008107) alpha-(1,2)-fucosyltransferase activity(GO:0031127) |
0.2 | 0.5 | GO:0004814 | arginine-tRNA ligase activity(GO:0004814) |
0.2 | 0.5 | GO:0070052 | collagen V binding(GO:0070052) |
0.2 | 1.7 | GO:0070016 | armadillo repeat domain binding(GO:0070016) |
0.2 | 0.5 | GO:0070742 | C2H2 zinc finger domain binding(GO:0070742) |
0.2 | 0.3 | GO:0070653 | high-density lipoprotein particle receptor binding(GO:0070653) |
0.2 | 2.1 | GO:0042923 | neuropeptide binding(GO:0042923) |
0.2 | 2.1 | GO:0099589 | G-protein coupled serotonin receptor activity(GO:0004993) serotonin receptor activity(GO:0099589) |
0.2 | 0.5 | GO:0008449 | N-acetylglucosamine-6-sulfatase activity(GO:0008449) |
0.2 | 3.6 | GO:0042056 | chemoattractant activity(GO:0042056) |
0.2 | 0.3 | GO:0070840 | dynein complex binding(GO:0070840) |
0.1 | 0.4 | GO:0008427 | calcium-dependent protein kinase inhibitor activity(GO:0008427) |
0.1 | 2.1 | GO:0035255 | ionotropic glutamate receptor binding(GO:0035255) |
0.1 | 1.6 | GO:0042043 | neurexin family protein binding(GO:0042043) |
0.1 | 5.3 | GO:0019894 | kinesin binding(GO:0019894) |
0.1 | 0.6 | GO:0031749 | D2 dopamine receptor binding(GO:0031749) |
0.1 | 3.1 | GO:0005227 | calcium activated cation channel activity(GO:0005227) |
0.1 | 0.9 | GO:0008093 | cytoskeletal adaptor activity(GO:0008093) |
0.1 | 0.9 | GO:0022835 | transmitter-gated ion channel activity(GO:0022824) transmitter-gated channel activity(GO:0022835) |
0.1 | 1.1 | GO:0001055 | RNA polymerase II activity(GO:0001055) |
0.1 | 1.0 | GO:0016308 | 1-phosphatidylinositol-4-phosphate 5-kinase activity(GO:0016308) |
0.1 | 0.6 | GO:0031694 | alpha-2A adrenergic receptor binding(GO:0031694) |
0.1 | 0.6 | GO:0035613 | RNA stem-loop binding(GO:0035613) |
0.1 | 0.4 | GO:0004832 | valine-tRNA ligase activity(GO:0004832) |
0.1 | 1.3 | GO:0042500 | aspartic endopeptidase activity, intramembrane cleaving(GO:0042500) |
0.1 | 0.3 | GO:0005128 | erythropoietin receptor binding(GO:0005128) |
0.1 | 0.7 | GO:0001601 | peptide YY receptor activity(GO:0001601) |
0.1 | 0.4 | GO:0031698 | beta-2 adrenergic receptor binding(GO:0031698) |
0.1 | 0.4 | GO:0070573 | metallodipeptidase activity(GO:0070573) |
0.1 | 2.0 | GO:0004889 | acetylcholine-activated cation-selective channel activity(GO:0004889) |
0.1 | 0.3 | GO:0019211 | phosphatase activator activity(GO:0019211) |
0.1 | 2.7 | GO:0005104 | fibroblast growth factor receptor binding(GO:0005104) |
0.1 | 1.5 | GO:0005522 | profilin binding(GO:0005522) |
0.1 | 0.7 | GO:0035014 | phosphatidylinositol 3-kinase regulator activity(GO:0035014) |
0.1 | 0.4 | GO:0046848 | hydroxyapatite binding(GO:0046848) |
0.1 | 0.5 | GO:0004594 | pantothenate kinase activity(GO:0004594) |
0.1 | 3.2 | GO:0004864 | protein phosphatase inhibitor activity(GO:0004864) |
0.1 | 0.8 | GO:0008121 | ubiquinol-cytochrome-c reductase activity(GO:0008121) oxidoreductase activity, acting on diphenols and related substances as donors, cytochrome as acceptor(GO:0016681) |
0.1 | 0.5 | GO:0019145 | aminobutyraldehyde dehydrogenase activity(GO:0019145) 4-trimethylammoniobutyraldehyde dehydrogenase activity(GO:0047105) |
0.1 | 1.1 | GO:0008568 | microtubule-severing ATPase activity(GO:0008568) |
0.1 | 0.8 | GO:0008517 | folic acid transporter activity(GO:0008517) |
0.1 | 0.1 | GO:0003696 | satellite DNA binding(GO:0003696) |
0.1 | 1.0 | GO:0008504 | monoamine transmembrane transporter activity(GO:0008504) |
0.1 | 1.4 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
0.1 | 2.6 | GO:0046875 | ephrin receptor binding(GO:0046875) |
0.1 | 0.4 | GO:0038085 | vascular endothelial growth factor binding(GO:0038085) |
0.1 | 0.4 | GO:0055131 | C3HC4-type RING finger domain binding(GO:0055131) |
0.1 | 1.0 | GO:0015321 | sodium-dependent phosphate transmembrane transporter activity(GO:0015321) |
0.1 | 0.7 | GO:0052630 | CTP:2,3-di-O-geranylgeranyl-sn-glycero-1-phosphate cytidyltransferase activity(GO:0043338) phospholactate guanylyltransferase activity(GO:0043814) ATP:coenzyme F420 adenylyltransferase activity(GO:0043910) UDP-N-acetylgalactosamine diphosphorylase activity(GO:0052630) |
0.1 | 0.7 | GO:0030957 | Tat protein binding(GO:0030957) |
0.1 | 0.7 | GO:0043495 | protein anchor(GO:0043495) |
0.1 | 0.6 | GO:0004983 | neuropeptide Y receptor activity(GO:0004983) |
0.1 | 0.3 | GO:0050694 | galactose 3-O-sulfotransferase activity(GO:0050694) |
0.1 | 0.5 | GO:1904288 | BAT3 complex binding(GO:1904288) |
0.1 | 0.5 | GO:0038132 | neuregulin binding(GO:0038132) |
0.1 | 0.6 | GO:0005432 | calcium:sodium antiporter activity(GO:0005432) |
0.1 | 0.4 | GO:0004897 | ciliary neurotrophic factor receptor activity(GO:0004897) |
0.1 | 0.3 | GO:0004605 | phosphatidate cytidylyltransferase activity(GO:0004605) |
0.1 | 2.0 | GO:0043014 | alpha-tubulin binding(GO:0043014) |
0.1 | 3.4 | GO:0015459 | potassium channel regulator activity(GO:0015459) |
0.1 | 1.7 | GO:0008188 | neuropeptide receptor activity(GO:0008188) |
0.1 | 0.5 | GO:0008294 | calcium- and calmodulin-responsive adenylate cyclase activity(GO:0008294) |
0.1 | 95.7 | GO:0043565 | sequence-specific DNA binding(GO:0043565) |
0.1 | 0.3 | GO:0016971 | flavin-linked sulfhydryl oxidase activity(GO:0016971) |
0.1 | 0.2 | GO:0015186 | L-asparagine transmembrane transporter activity(GO:0015182) L-glutamine transmembrane transporter activity(GO:0015186) |
0.1 | 0.4 | GO:0004558 | alpha-1,4-glucosidase activity(GO:0004558) |
0.1 | 0.3 | GO:0016015 | morphogen activity(GO:0016015) |
0.1 | 0.5 | GO:0070051 | fibrinogen binding(GO:0070051) |
0.1 | 0.2 | GO:0008310 | single-stranded DNA 3'-5' exodeoxyribonuclease activity(GO:0008310) |
0.1 | 0.4 | GO:0016901 | oxidoreductase activity, acting on the CH-OH group of donors, quinone or similar compound as acceptor(GO:0016901) |
0.1 | 0.1 | GO:0001016 | RNA polymerase III regulatory region DNA binding(GO:0001016) |
0.1 | 0.3 | GO:0004949 | cannabinoid receptor activity(GO:0004949) |
0.1 | 0.7 | GO:0070181 | small ribosomal subunit rRNA binding(GO:0070181) |
0.1 | 0.6 | GO:0043208 | glycosphingolipid binding(GO:0043208) |
0.1 | 0.2 | GO:0004948 | calcitonin receptor activity(GO:0004948) |
0.1 | 0.9 | GO:0016215 | acyl-CoA desaturase activity(GO:0016215) |
0.1 | 0.5 | GO:0008526 | phosphatidylinositol transporter activity(GO:0008526) |
0.1 | 0.5 | GO:0005499 | vitamin D binding(GO:0005499) |
0.1 | 0.4 | GO:0004090 | carbonyl reductase (NADPH) activity(GO:0004090) |
0.1 | 1.2 | GO:0008601 | protein phosphatase type 2A regulator activity(GO:0008601) |
0.1 | 0.1 | GO:0030297 | transmembrane receptor protein tyrosine kinase activator activity(GO:0030297) |
0.1 | 0.2 | GO:0004667 | prostaglandin-D synthase activity(GO:0004667) |
0.1 | 1.0 | GO:0008519 | ammonium transmembrane transporter activity(GO:0008519) |
0.1 | 0.4 | GO:0019808 | polyamine binding(GO:0019808) |
0.1 | 1.2 | GO:0004435 | phosphatidylinositol phospholipase C activity(GO:0004435) |
0.1 | 0.3 | GO:0030144 | alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase activity(GO:0030144) |
0.1 | 0.3 | GO:0046978 | TAP1 binding(GO:0046978) TAP2 binding(GO:0046979) |
0.1 | 0.3 | GO:0035651 | AP-3 adaptor complex binding(GO:0035651) |
0.1 | 2.2 | GO:0001540 | beta-amyloid binding(GO:0001540) |
0.1 | 0.3 | GO:1990254 | keratin filament binding(GO:1990254) |
0.1 | 0.6 | GO:0017070 | U6 snRNA binding(GO:0017070) |
0.1 | 1.1 | GO:0042800 | histone methyltransferase activity (H3-K4 specific)(GO:0042800) |
0.1 | 0.8 | GO:0015172 | L-glutamate transmembrane transporter activity(GO:0005313) acidic amino acid transmembrane transporter activity(GO:0015172) |
0.1 | 0.5 | GO:0005113 | patched binding(GO:0005113) |
0.1 | 0.2 | GO:0008147 | structural constituent of bone(GO:0008147) |
0.1 | 0.3 | GO:0008494 | translation activator activity(GO:0008494) |
0.1 | 0.2 | GO:0097157 | pre-mRNA intronic binding(GO:0097157) |
0.1 | 0.2 | GO:0070137 | ubiquitin-like protein-specific endopeptidase activity(GO:0070137) SUMO-specific endopeptidase activity(GO:0070139) |
0.1 | 0.8 | GO:0034185 | apolipoprotein binding(GO:0034185) |
0.1 | 0.2 | GO:0008502 | melatonin receptor activity(GO:0008502) |
0.1 | 0.3 | GO:0034584 | piRNA binding(GO:0034584) |
0.1 | 0.6 | GO:0097027 | ubiquitin-protein transferase activator activity(GO:0097027) |
0.1 | 0.2 | GO:1990825 | sequence-specific mRNA binding(GO:1990825) |
0.1 | 0.4 | GO:0050733 | RS domain binding(GO:0050733) |
0.1 | 0.8 | GO:0019531 | oxalate transmembrane transporter activity(GO:0019531) |
0.1 | 0.5 | GO:0005338 | nucleotide-sugar transmembrane transporter activity(GO:0005338) |
0.1 | 0.2 | GO:0071074 | eukaryotic initiation factor eIF2 binding(GO:0071074) |
0.1 | 0.2 | GO:0030280 | structural constituent of epidermis(GO:0030280) |
0.1 | 0.4 | GO:0003847 | 1-alkyl-2-acetylglycerophosphocholine esterase activity(GO:0003847) |
0.1 | 0.1 | GO:0070915 | lysophosphatidic acid receptor activity(GO:0070915) |
0.1 | 0.1 | GO:0035197 | siRNA binding(GO:0035197) |
0.1 | 1.2 | GO:0005242 | inward rectifier potassium channel activity(GO:0005242) |
0.1 | 0.4 | GO:0047035 | testosterone dehydrogenase (NAD+) activity(GO:0047035) |
0.1 | 1.2 | GO:0042813 | Wnt-activated receptor activity(GO:0042813) |
0.1 | 0.1 | GO:0017153 | sodium:dicarboxylate symporter activity(GO:0017153) |
0.1 | 0.4 | GO:0032027 | myosin light chain binding(GO:0032027) |
0.1 | 1.2 | GO:0031489 | myosin V binding(GO:0031489) |
0.1 | 1.1 | GO:0015026 | coreceptor activity(GO:0015026) |
0.1 | 0.2 | GO:0050510 | N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase activity(GO:0050510) |
0.1 | 1.3 | GO:0005184 | neuropeptide hormone activity(GO:0005184) |
0.1 | 0.1 | GO:0003846 | 2-acylglycerol O-acyltransferase activity(GO:0003846) |
0.1 | 0.3 | GO:0031730 | CCR5 chemokine receptor binding(GO:0031730) |
0.1 | 0.3 | GO:0016803 | ether hydrolase activity(GO:0016803) |
0.1 | 0.2 | GO:0019166 | trans-2-enoyl-CoA reductase (NADPH) activity(GO:0019166) |
0.1 | 0.4 | GO:0004908 | interleukin-1 receptor activity(GO:0004908) |
0.1 | 0.7 | GO:0016813 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines(GO:0016813) |
0.1 | 0.3 | GO:0004791 | thioredoxin-disulfide reductase activity(GO:0004791) |
0.1 | 0.2 | GO:0015651 | quaternary ammonium group transmembrane transporter activity(GO:0015651) |
0.1 | 0.9 | GO:0043395 | heparan sulfate proteoglycan binding(GO:0043395) |
0.1 | 0.2 | GO:0016520 | growth hormone-releasing hormone receptor activity(GO:0016520) |
0.1 | 0.1 | GO:0048273 | mitogen-activated protein kinase p38 binding(GO:0048273) |
0.1 | 0.4 | GO:0039706 | co-receptor binding(GO:0039706) |
0.1 | 0.5 | GO:0030553 | cGMP binding(GO:0030553) |
0.1 | 1.5 | GO:0030507 | spectrin binding(GO:0030507) |
0.1 | 0.1 | GO:0004126 | cytidine deaminase activity(GO:0004126) |
0.1 | 1.8 | GO:0005504 | fatty acid binding(GO:0005504) |
0.1 | 0.6 | GO:0045236 | CXCR chemokine receptor binding(GO:0045236) |
0.1 | 1.9 | GO:0051018 | protein kinase A binding(GO:0051018) |
0.1 | 0.2 | GO:0008273 | calcium, potassium:sodium antiporter activity(GO:0008273) |
0.1 | 0.3 | GO:0017099 | very-long-chain-acyl-CoA dehydrogenase activity(GO:0017099) |
0.1 | 0.2 | GO:0004945 | angiotensin type II receptor activity(GO:0004945) |
0.1 | 0.2 | GO:0008499 | UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity(GO:0008499) |
0.1 | 0.4 | GO:0016413 | O-acetyltransferase activity(GO:0016413) |
0.1 | 0.5 | GO:0016857 | racemase and epimerase activity, acting on carbohydrates and derivatives(GO:0016857) |
0.1 | 0.3 | GO:0047498 | calcium-dependent phospholipase A2 activity(GO:0047498) |
0.1 | 0.3 | GO:0046624 | sphingolipid transporter activity(GO:0046624) |
0.1 | 0.2 | GO:0003829 | beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity(GO:0003829) |
0.1 | 0.2 | GO:0042284 | sphingolipid delta-4 desaturase activity(GO:0042284) |
0.1 | 0.1 | GO:0045340 | mercury ion binding(GO:0045340) |
0.1 | 0.3 | GO:0015198 | oligopeptide transporter activity(GO:0015198) |
0.1 | 0.8 | GO:0005267 | potassium channel activity(GO:0005267) |
0.1 | 0.5 | GO:0070180 | large ribosomal subunit rRNA binding(GO:0070180) |
0.1 | 0.2 | GO:0004813 | alanine-tRNA ligase activity(GO:0004813) |
0.1 | 0.2 | GO:1990226 | histone methyltransferase binding(GO:1990226) |
0.1 | 0.4 | GO:0035259 | glucocorticoid receptor binding(GO:0035259) |
0.1 | 0.6 | GO:0016917 | GABA receptor activity(GO:0016917) |
0.1 | 0.3 | GO:0004075 | biotin carboxylase activity(GO:0004075) |
0.0 | 0.1 | GO:0004800 | thyroxine 5'-deiodinase activity(GO:0004800) |
0.0 | 0.1 | GO:0043533 | inositol 1,3,4,5 tetrakisphosphate binding(GO:0043533) |
0.0 | 0.2 | GO:0052834 | inositol monophosphate 1-phosphatase activity(GO:0008934) inositol monophosphate 3-phosphatase activity(GO:0052832) inositol monophosphate 4-phosphatase activity(GO:0052833) inositol monophosphate phosphatase activity(GO:0052834) |
0.0 | 0.3 | GO:0047372 | acylglycerol lipase activity(GO:0047372) |
0.0 | 0.7 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
0.0 | 0.2 | GO:0047631 | ADP-ribose diphosphatase activity(GO:0047631) |
0.0 | 0.2 | GO:0010851 | cyclase regulator activity(GO:0010851) |
0.0 | 0.1 | GO:0042392 | sphingosine-1-phosphate phosphatase activity(GO:0042392) |
0.0 | 0.9 | GO:0005246 | calcium channel regulator activity(GO:0005246) |
0.0 | 0.2 | GO:0004735 | pyrroline-5-carboxylate reductase activity(GO:0004735) |
0.0 | 0.1 | GO:0004461 | lactose synthase activity(GO:0004461) |
0.0 | 0.9 | GO:0016701 | oxidoreductase activity, acting on single donors with incorporation of molecular oxygen(GO:0016701) |
0.0 | 0.0 | GO:1990932 | 5.8S rRNA binding(GO:1990932) |
0.0 | 0.3 | GO:0050291 | sphingosine N-acyltransferase activity(GO:0050291) |
0.0 | 0.1 | GO:0015157 | sucrose:proton symporter activity(GO:0008506) sucrose transmembrane transporter activity(GO:0008515) disaccharide transmembrane transporter activity(GO:0015154) oligosaccharide transmembrane transporter activity(GO:0015157) |
0.0 | 0.2 | GO:0016019 | N-acetylmuramoyl-L-alanine amidase activity(GO:0008745) peptidoglycan receptor activity(GO:0016019) |
0.0 | 0.0 | GO:0016679 | oxidoreductase activity, acting on diphenols and related substances as donors(GO:0016679) |
0.0 | 0.1 | GO:0003917 | DNA topoisomerase type I activity(GO:0003917) |
0.0 | 0.1 | GO:0005078 | MAP-kinase scaffold activity(GO:0005078) |
0.0 | 0.1 | GO:0047499 | calcium-independent phospholipase A2 activity(GO:0047499) |
0.0 | 0.2 | GO:0004652 | polynucleotide adenylyltransferase activity(GO:0004652) |
0.0 | 0.1 | GO:0005131 | growth hormone receptor binding(GO:0005131) |
0.0 | 0.8 | GO:0004181 | metallocarboxypeptidase activity(GO:0004181) |
0.0 | 0.3 | GO:0070679 | inositol 1,4,5 trisphosphate binding(GO:0070679) |
0.0 | 0.1 | GO:0030375 | thyroid hormone receptor coactivator activity(GO:0030375) |
0.0 | 0.1 | GO:0015562 | efflux transmembrane transporter activity(GO:0015562) |
0.0 | 0.2 | GO:0030942 | endoplasmic reticulum signal peptide binding(GO:0030942) |
0.0 | 0.1 | GO:0031871 | proteinase activated receptor binding(GO:0031871) |
0.0 | 0.5 | GO:0001106 | RNA polymerase II transcription corepressor activity(GO:0001106) |
0.0 | 0.1 | GO:0097016 | L27 domain binding(GO:0097016) |
0.0 | 0.2 | GO:0016176 | superoxide-generating NADPH oxidase activator activity(GO:0016176) |
0.0 | 0.4 | GO:0031490 | chromatin DNA binding(GO:0031490) |
0.0 | 0.3 | GO:0017147 | Wnt-protein binding(GO:0017147) |
0.0 | 0.1 | GO:0060228 | phosphatidylcholine-sterol O-acyltransferase activator activity(GO:0060228) |
0.0 | 0.1 | GO:1990430 | extracellular matrix protein binding(GO:1990430) |
0.0 | 0.1 | GO:0030021 | extracellular matrix structural constituent conferring compression resistance(GO:0030021) structural constituent of tooth enamel(GO:0030345) |
0.0 | 1.1 | GO:0016418 | S-acetyltransferase activity(GO:0016418) |
0.0 | 0.0 | GO:0004977 | melanocortin receptor activity(GO:0004977) |
0.0 | 0.4 | GO:0016805 | dipeptidase activity(GO:0016805) |
0.0 | 0.1 | GO:0008900 | hydrogen:potassium-exchanging ATPase activity(GO:0008900) |
0.0 | 0.0 | GO:0008158 | hedgehog receptor activity(GO:0008158) |
0.0 | 0.1 | GO:0051380 | norepinephrine binding(GO:0051380) |
0.0 | 0.1 | GO:0019862 | IgA binding(GO:0019862) |
0.0 | 0.7 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
0.0 | 0.1 | GO:0043842 | Kdo transferase activity(GO:0043842) |
0.0 | 0.1 | GO:0000403 | Y-form DNA binding(GO:0000403) |
0.0 | 0.1 | GO:0031708 | endothelin B receptor binding(GO:0031708) |
0.0 | 0.2 | GO:0103116 | alpha-D-galactofuranose transporter activity(GO:0103116) |
0.0 | 0.2 | GO:0046977 | TAP binding(GO:0046977) |
0.0 | 3.6 | GO:0003729 | mRNA binding(GO:0003729) |
0.0 | 0.1 | GO:0048406 | nerve growth factor binding(GO:0048406) |
0.0 | 0.1 | GO:0004656 | procollagen-proline 4-dioxygenase activity(GO:0004656) |
0.0 | 0.1 | GO:0046912 | transferase activity, transferring acyl groups, acyl groups converted into alkyl on transfer(GO:0046912) |
0.0 | 0.1 | GO:0004749 | ribose phosphate diphosphokinase activity(GO:0004749) |
0.0 | 0.4 | GO:0070001 | aspartic-type endopeptidase activity(GO:0004190) aspartic-type peptidase activity(GO:0070001) |
0.0 | 1.3 | GO:0008376 | acetylgalactosaminyltransferase activity(GO:0008376) |
0.0 | 1.4 | GO:0019905 | syntaxin binding(GO:0019905) |
0.0 | 0.1 | GO:0004974 | leukotriene receptor activity(GO:0004974) |
0.0 | 0.3 | GO:0017056 | structural constituent of nuclear pore(GO:0017056) |
0.0 | 0.1 | GO:0061513 | hexose phosphate transmembrane transporter activity(GO:0015119) organophosphate:inorganic phosphate antiporter activity(GO:0015315) hexose-phosphate:inorganic phosphate antiporter activity(GO:0015526) glucose 6-phosphate:inorganic phosphate antiporter activity(GO:0061513) |
0.0 | 0.1 | GO:0034711 | inhibin binding(GO:0034711) |
0.0 | 0.1 | GO:0016174 | NAD(P)H oxidase activity(GO:0016174) |
0.0 | 0.1 | GO:0047555 | 3',5'-cyclic-GMP phosphodiesterase activity(GO:0047555) |
0.0 | 0.3 | GO:0008574 | ATP-dependent microtubule motor activity, plus-end-directed(GO:0008574) |
0.0 | 0.1 | GO:0004523 | RNA-DNA hybrid ribonuclease activity(GO:0004523) |
0.0 | 0.1 | GO:0008432 | JUN kinase binding(GO:0008432) |
0.0 | 0.6 | GO:0052634 | sulfonate dioxygenase activity(GO:0000907) 2,4-dichlorophenoxyacetate alpha-ketoglutarate dioxygenase activity(GO:0018602) hypophosphite dioxygenase activity(GO:0034792) gibberellin 2-beta-dioxygenase activity(GO:0045543) C-19 gibberellin 2-beta-dioxygenase activity(GO:0052634) C-20 gibberellin 2-beta-dioxygenase activity(GO:0052635) |
0.0 | 0.5 | GO:0005109 | frizzled binding(GO:0005109) |
0.0 | 0.1 | GO:0070567 | cytidylyltransferase activity(GO:0070567) |
0.0 | 0.1 | GO:0031419 | cobalamin binding(GO:0031419) |
0.0 | 0.2 | GO:0030228 | lipoprotein particle receptor activity(GO:0030228) |
0.0 | 0.1 | GO:0070888 | E-box binding(GO:0070888) |
0.0 | 0.3 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
0.0 | 0.0 | GO:0017162 | aryl hydrocarbon receptor binding(GO:0017162) |
0.0 | 0.5 | GO:0015347 | sodium-independent organic anion transmembrane transporter activity(GO:0015347) |
0.0 | 0.1 | GO:0017150 | tRNA dihydrouridine synthase activity(GO:0017150) |
0.0 | 0.1 | GO:0046933 | proton-transporting ATP synthase activity, rotational mechanism(GO:0046933) |
0.0 | 0.1 | GO:0043262 | adenosine-diphosphatase activity(GO:0043262) |
0.0 | 0.3 | GO:0005355 | glucose transmembrane transporter activity(GO:0005355) |
0.0 | 0.1 | GO:0002151 | G-quadruplex RNA binding(GO:0002151) |
0.0 | 0.2 | GO:0031957 | very long-chain fatty acid-CoA ligase activity(GO:0031957) |
0.0 | 0.1 | GO:0008140 | cAMP response element binding protein binding(GO:0008140) |
0.0 | 0.0 | GO:0016880 | acid-ammonia (or amide) ligase activity(GO:0016880) |
0.0 | 0.1 | GO:0050309 | glucose-6-phosphatase activity(GO:0004346) sugar-terminal-phosphatase activity(GO:0050309) |
0.0 | 0.1 | GO:0003705 | transcription factor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0003705) |
0.0 | 0.0 | GO:0035529 | NADH pyrophosphatase activity(GO:0035529) |
0.0 | 0.2 | GO:0043274 | phospholipase binding(GO:0043274) |
0.0 | 0.0 | GO:0002046 | opsin binding(GO:0002046) |
0.0 | 0.1 | GO:0045504 | dynein heavy chain binding(GO:0045504) |
0.0 | 0.1 | GO:0005502 | 11-cis retinal binding(GO:0005502) |
0.0 | 1.3 | GO:0005179 | hormone activity(GO:0005179) |
0.0 | 0.1 | GO:0034618 | arginine binding(GO:0034618) |
0.0 | 0.1 | GO:0030169 | low-density lipoprotein particle binding(GO:0030169) |
0.0 | 0.0 | GO:0030158 | protein xylosyltransferase activity(GO:0030158) |
0.0 | 0.1 | GO:0004308 | exo-alpha-sialidase activity(GO:0004308) alpha-sialidase activity(GO:0016997) exo-alpha-(2->3)-sialidase activity(GO:0052794) exo-alpha-(2->6)-sialidase activity(GO:0052795) exo-alpha-(2->8)-sialidase activity(GO:0052796) |
0.0 | 0.0 | GO:0042281 | dolichyl pyrophosphate Man9GlcNAc2 alpha-1,3-glucosyltransferase activity(GO:0042281) |
0.0 | 0.1 | GO:0004415 | hyalurononglucosaminidase activity(GO:0004415) |
0.0 | 0.1 | GO:0034511 | U3 snoRNA binding(GO:0034511) |
0.0 | 0.1 | GO:0046790 | virion binding(GO:0046790) |
0.0 | 0.3 | GO:0042054 | histone methyltransferase activity(GO:0042054) |
0.0 | 0.0 | GO:0031735 | CCR10 chemokine receptor binding(GO:0031735) |
0.0 | 0.1 | GO:0004576 | oligosaccharyl transferase activity(GO:0004576) |
0.0 | 0.0 | GO:0019767 | IgE receptor activity(GO:0019767) |
0.0 | 0.3 | GO:0031683 | G-protein beta/gamma-subunit complex binding(GO:0031683) |
0.0 | 0.3 | GO:0008009 | chemokine activity(GO:0008009) |
0.0 | 0.3 | GO:0042169 | SH2 domain binding(GO:0042169) |
0.0 | 0.0 | GO:0071558 | histone demethylase activity (H3-K9 specific)(GO:0032454) histone demethylase activity (H3-K27 specific)(GO:0071558) |
0.0 | 0.1 | GO:1990381 | ubiquitin-specific protease binding(GO:1990381) |
0.0 | 0.1 | GO:0070182 | DNA polymerase binding(GO:0070182) |
0.0 | 0.1 | GO:0005000 | vasopressin receptor activity(GO:0005000) |
0.0 | 0.4 | GO:0000049 | tRNA binding(GO:0000049) |
0.0 | 0.0 | GO:0019863 | IgE binding(GO:0019863) |
0.0 | 0.1 | GO:0008097 | 5S rRNA binding(GO:0008097) |
0.0 | 0.1 | GO:0016713 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced iron-sulfur protein as one donor, and incorporation of one atom of oxygen(GO:0016713) |
0.0 | 0.0 | GO:0032190 | acrosin binding(GO:0032190) |
0.0 | 1.0 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
0.0 | 0.1 | GO:0030983 | mismatched DNA binding(GO:0030983) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.3 | 9.8 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
0.3 | 0.3 | PID MAPK TRK PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
0.3 | 7.5 | PID LIS1 PATHWAY | Lissencephaly gene (LIS1) in neuronal migration and development |
0.2 | 0.2 | SA B CELL RECEPTOR COMPLEXES | Antigen binding to B cell receptors activates protein tyrosine kinases, such as the Src family, which ultimate activate MAP kinases. |
0.2 | 0.4 | PID INTEGRIN4 PATHWAY | Alpha6 beta4 integrin-ligand interactions |
0.2 | 2.8 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
0.2 | 5.2 | PID NETRIN PATHWAY | Netrin-mediated signaling events |
0.2 | 2.2 | PID BETA CATENIN DEG PATHWAY | Degradation of beta catenin |
0.1 | 0.3 | PID NFAT 3PATHWAY | Role of Calcineurin-dependent NFAT signaling in lymphocytes |
0.1 | 2.2 | PID REELIN PATHWAY | Reelin signaling pathway |
0.1 | 0.7 | PID ECADHERIN KERATINOCYTE PATHWAY | E-cadherin signaling in keratinocytes |
0.1 | 3.3 | PID EPHA FWDPATHWAY | EPHA forward signaling |
0.1 | 2.0 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
0.1 | 0.9 | PID EPHB FWD PATHWAY | EPHB forward signaling |
0.1 | 0.3 | PID HDAC CLASSII PATHWAY | Signaling events mediated by HDAC Class II |
0.1 | 0.1 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
0.1 | 1.2 | PID ALK2 PATHWAY | ALK2 signaling events |
0.1 | 1.4 | PID PS1 PATHWAY | Presenilin action in Notch and Wnt signaling |
0.1 | 2.2 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
0.1 | 0.2 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
0.1 | 1.8 | PID NEPHRIN NEPH1 PATHWAY | Nephrin/Neph1 signaling in the kidney podocyte |
0.1 | 1.4 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
0.1 | 1.7 | PID HDAC CLASSIII PATHWAY | Signaling events mediated by HDAC Class III |
0.1 | 1.1 | ST GRANULE CELL SURVIVAL PATHWAY | Granule Cell Survival Pathway is a specific case of more general PAC1 Receptor Pathway. |
0.1 | 2.7 | PID TRKR PATHWAY | Neurotrophic factor-mediated Trk receptor signaling |
0.1 | 4.2 | PID BETA CATENIN NUC PATHWAY | Regulation of nuclear beta catenin signaling and target gene transcription |
0.1 | 1.0 | PID RET PATHWAY | Signaling events regulated by Ret tyrosine kinase |
0.1 | 0.7 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
0.1 | 0.5 | PID S1P S1P4 PATHWAY | S1P4 pathway |
0.0 | 0.9 | PID NCADHERIN PATHWAY | N-cadherin signaling events |
0.0 | 0.6 | PID ERBB4 PATHWAY | ErbB4 signaling events |
0.0 | 0.3 | PID IFNG PATHWAY | IFN-gamma pathway |
0.0 | 0.1 | ST INTERFERON GAMMA PATHWAY | Interferon gamma pathway. |
0.0 | 0.3 | PID AR NONGENOMIC PATHWAY | Nongenotropic Androgen signaling |
0.0 | 0.2 | ST IL 13 PATHWAY | Interleukin 13 (IL-13) Pathway |
0.0 | 5.0 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
0.0 | 0.1 | PID EPHA2 FWD PATHWAY | EPHA2 forward signaling |
0.0 | 0.5 | PID AURORA A PATHWAY | Aurora A signaling |
0.0 | 0.0 | PID P38 GAMMA DELTA PATHWAY | Signaling mediated by p38-gamma and p38-delta |
0.0 | 0.4 | PID CDC42 PATHWAY | CDC42 signaling events |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.1 | 1.1 | REACTOME INCRETIN SYNTHESIS SECRETION AND INACTIVATION | Genes involved in Incretin Synthesis, Secretion, and Inactivation |
0.8 | 2.4 | REACTOME ACETYLCHOLINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Acetylcholine Neurotransmitter Release Cycle |
0.7 | 0.7 | REACTOME OLFACTORY SIGNALING PATHWAY | Genes involved in Olfactory Signaling Pathway |
0.6 | 8.3 | REACTOME UNBLOCKING OF NMDA RECEPTOR GLUTAMATE BINDING AND ACTIVATION | Genes involved in Unblocking of NMDA receptor, glutamate binding and activation |
0.5 | 8.3 | REACTOME GABA SYNTHESIS RELEASE REUPTAKE AND DEGRADATION | Genes involved in GABA synthesis, release, reuptake and degradation |
0.4 | 5.9 | REACTOME CRMPS IN SEMA3A SIGNALING | Genes involved in CRMPs in Sema3A signaling |
0.4 | 5.6 | REACTOME CLASS C 3 METABOTROPIC GLUTAMATE PHEROMONE RECEPTORS | Genes involved in Class C/3 (Metabotropic glutamate/pheromone receptors) |
0.4 | 6.0 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GLP1 | Genes involved in Synthesis, Secretion, and Inactivation of Glucagon-like Peptide-1 (GLP-1) |
0.3 | 6.3 | REACTOME LIGAND GATED ION CHANNEL TRANSPORT | Genes involved in Ligand-gated ion channel transport |
0.3 | 0.3 | REACTOME REGULATION OF INSULIN SECRETION | Genes involved in Regulation of Insulin Secretion |
0.3 | 3.1 | REACTOME IONOTROPIC ACTIVITY OF KAINATE RECEPTORS | Genes involved in Ionotropic activity of Kainate Receptors |
0.3 | 9.8 | REACTOME NETRIN1 SIGNALING | Genes involved in Netrin-1 signaling |
0.3 | 2.9 | REACTOME TANDEM PORE DOMAIN POTASSIUM CHANNELS | Genes involved in Tandem pore domain potassium channels |
0.2 | 0.2 | REACTOME PROSTACYCLIN SIGNALLING THROUGH PROSTACYCLIN RECEPTOR | Genes involved in Prostacyclin signalling through prostacyclin receptor |
0.2 | 0.7 | REACTOME RAP1 SIGNALLING | Genes involved in Rap1 signalling |
0.2 | 2.2 | REACTOME G PROTEIN ACTIVATION | Genes involved in G-protein activation |
0.2 | 17.5 | REACTOME CLASS B 2 SECRETIN FAMILY RECEPTORS | Genes involved in Class B/2 (Secretin family receptors) |
0.2 | 8.4 | REACTOME NCAM1 INTERACTIONS | Genes involved in NCAM1 interactions |
0.2 | 1.7 | REACTOME DSCAM INTERACTIONS | Genes involved in DSCAM interactions |
0.2 | 9.0 | REACTOME VOLTAGE GATED POTASSIUM CHANNELS | Genes involved in Voltage gated Potassium channels |
0.2 | 1.2 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
0.2 | 3.0 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
0.2 | 2.1 | REACTOME HIGHLY CALCIUM PERMEABLE POSTSYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Highly calcium permeable postsynaptic nicotinic acetylcholine receptors |
0.2 | 0.2 | REACTOME ACYL CHAIN REMODELLING OF PI | Genes involved in Acyl chain remodelling of PI |
0.2 | 0.2 | REACTOME TRAF3 DEPENDENT IRF ACTIVATION PATHWAY | Genes involved in TRAF3-dependent IRF activation pathway |
0.2 | 2.9 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
0.2 | 1.9 | REACTOME SEROTONIN RECEPTORS | Genes involved in Serotonin receptors |
0.2 | 0.6 | REACTOME DOPAMINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Dopamine Neurotransmitter Release Cycle |
0.2 | 0.3 | REACTOME ALPHA LINOLENIC ACID ALA METABOLISM | Genes involved in alpha-linolenic acid (ALA) metabolism |
0.2 | 0.3 | REACTOME ACYL CHAIN REMODELLING OF PS | Genes involved in Acyl chain remodelling of PS |
0.2 | 2.2 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
0.2 | 0.9 | REACTOME ACTIVATED POINT MUTANTS OF FGFR2 | Genes involved in Activated point mutants of FGFR2 |
0.2 | 1.7 | REACTOME SIGNALING BY FGFR3 MUTANTS | Genes involved in Signaling by FGFR3 mutants |
0.1 | 2.9 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
0.1 | 4.1 | REACTOME HS GAG BIOSYNTHESIS | Genes involved in HS-GAG biosynthesis |
0.1 | 0.1 | REACTOME SCFSKP2 MEDIATED DEGRADATION OF P27 P21 | Genes involved in SCF(Skp2)-mediated degradation of p27/p21 |
0.1 | 3.3 | REACTOME CYTOCHROME P450 ARRANGED BY SUBSTRATE TYPE | Genes involved in Cytochrome P450 - arranged by substrate type |
0.1 | 1.4 | REACTOME INITIAL TRIGGERING OF COMPLEMENT | Genes involved in Initial triggering of complement |
0.1 | 2.2 | REACTOME TRAFFICKING OF AMPA RECEPTORS | Genes involved in Trafficking of AMPA receptors |
0.1 | 1.1 | REACTOME CYTOSOLIC SULFONATION OF SMALL MOLECULES | Genes involved in Cytosolic sulfonation of small molecules |
0.1 | 1.8 | REACTOME POST CHAPERONIN TUBULIN FOLDING PATHWAY | Genes involved in Post-chaperonin tubulin folding pathway |
0.1 | 2.0 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
0.1 | 1.2 | REACTOME ORGANIC CATION ANION ZWITTERION TRANSPORT | Genes involved in Organic cation/anion/zwitterion transport |
0.1 | 1.2 | REACTOME NA CL DEPENDENT NEUROTRANSMITTER TRANSPORTERS | Genes involved in Na+/Cl- dependent neurotransmitter transporters |
0.1 | 2.3 | REACTOME NITRIC OXIDE STIMULATES GUANYLATE CYCLASE | Genes involved in Nitric oxide stimulates guanylate cyclase |
0.1 | 0.9 | REACTOME COPI MEDIATED TRANSPORT | Genes involved in COPI Mediated Transport |
0.1 | 0.9 | REACTOME REGULATED PROTEOLYSIS OF P75NTR | Genes involved in Regulated proteolysis of p75NTR |
0.1 | 1.4 | REACTOME N GLYCAN ANTENNAE ELONGATION IN THE MEDIAL TRANS GOLGI | Genes involved in N-glycan antennae elongation in the medial/trans-Golgi |
0.1 | 0.1 | REACTOME FGFR4 LIGAND BINDING AND ACTIVATION | Genes involved in FGFR4 ligand binding and activation |
0.1 | 1.5 | REACTOME ACTIVATED NOTCH1 TRANSMITS SIGNAL TO THE NUCLEUS | Genes involved in Activated NOTCH1 Transmits Signal to the Nucleus |
0.1 | 1.8 | REACTOME KINESINS | Genes involved in Kinesins |
0.1 | 0.2 | REACTOME BINDING AND ENTRY OF HIV VIRION | Genes involved in Binding and entry of HIV virion |
0.1 | 0.2 | REACTOME INFLAMMASOMES | Genes involved in Inflammasomes |
0.1 | 0.1 | REACTOME INTEGRATION OF ENERGY METABOLISM | Genes involved in Integration of energy metabolism |
0.1 | 0.5 | REACTOME RECYCLING OF BILE ACIDS AND SALTS | Genes involved in Recycling of bile acids and salts |
0.1 | 1.1 | REACTOME RNA POL III CHAIN ELONGATION | Genes involved in RNA Polymerase III Chain Elongation |
0.1 | 2.3 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |
0.1 | 1.5 | REACTOME POTASSIUM CHANNELS | Genes involved in Potassium Channels |
0.1 | 0.7 | REACTOME RESOLUTION OF AP SITES VIA THE SINGLE NUCLEOTIDE REPLACEMENT PATHWAY | Genes involved in Resolution of AP sites via the single-nucleotide replacement pathway |
0.1 | 9.5 | REACTOME PEPTIDE LIGAND BINDING RECEPTORS | Genes involved in Peptide ligand-binding receptors |
0.1 | 0.5 | REACTOME ADENYLATE CYCLASE INHIBITORY PATHWAY | Genes involved in Adenylate cyclase inhibitory pathway |
0.1 | 0.4 | REACTOME ADVANCED GLYCOSYLATION ENDPRODUCT RECEPTOR SIGNALING | Genes involved in Advanced glycosylation endproduct receptor signaling |
0.1 | 0.8 | REACTOME ACYL CHAIN REMODELLING OF PG | Genes involved in Acyl chain remodelling of PG |
0.0 | 0.9 | REACTOME RNA POL I TRANSCRIPTION INITIATION | Genes involved in RNA Polymerase I Transcription Initiation |
0.0 | 0.2 | REACTOME ABACAVIR TRANSPORT AND METABOLISM | Genes involved in Abacavir transport and metabolism |
0.0 | 0.9 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
0.0 | 0.4 | REACTOME PASSIVE TRANSPORT BY AQUAPORINS | Genes involved in Passive Transport by Aquaporins |
0.0 | 0.0 | REACTOME INHIBITION OF INSULIN SECRETION BY ADRENALINE NORADRENALINE | Genes involved in Inhibition of Insulin Secretion by Adrenaline/Noradrenaline |
0.0 | 0.4 | REACTOME PEPTIDE HORMONE BIOSYNTHESIS | Genes involved in Peptide hormone biosynthesis |
0.0 | 0.0 | REACTOME SPRY REGULATION OF FGF SIGNALING | Genes involved in Spry regulation of FGF signaling |
0.0 | 0.0 | REACTOME REGULATION OF GLUCOKINASE BY GLUCOKINASE REGULATORY PROTEIN | Genes involved in Regulation of Glucokinase by Glucokinase Regulatory Protein |
0.0 | 0.0 | REACTOME SIGNALING BY NOTCH3 | Genes involved in Signaling by NOTCH3 |
0.0 | 0.8 | REACTOME EXTRACELLULAR MATRIX ORGANIZATION | Genes involved in Extracellular matrix organization |
0.0 | 0.1 | REACTOME NOD1 2 SIGNALING PATHWAY | Genes involved in NOD1/2 Signaling Pathway |
0.0 | 0.1 | REACTOME ACETYLCHOLINE BINDING AND DOWNSTREAM EVENTS | Genes involved in Acetylcholine Binding And Downstream Events |
0.0 | 0.1 | REACTOME DESTABILIZATION OF MRNA BY AUF1 HNRNP D0 | Genes involved in Destabilization of mRNA by AUF1 (hnRNP D0) |
0.0 | 0.1 | REACTOME CROSS PRESENTATION OF SOLUBLE EXOGENOUS ANTIGENS ENDOSOMES | Genes involved in Cross-presentation of soluble exogenous antigens (endosomes) |
0.0 | 0.1 | REACTOME SHC MEDIATED SIGNALLING | Genes involved in SHC-mediated signalling |
0.0 | 0.1 | REACTOME RAS ACTIVATION UOPN CA2 INFUX THROUGH NMDA RECEPTOR | Genes involved in Ras activation uopn Ca2+ infux through NMDA receptor |
0.0 | 0.8 | REACTOME REGULATION OF BETA CELL DEVELOPMENT | Genes involved in Regulation of beta-cell development |
0.0 | 0.4 | REACTOME PROCESSING OF INTRONLESS PRE MRNAS | Genes involved in Processing of Intronless Pre-mRNAs |
0.0 | 0.3 | REACTOME VITAMIN B5 PANTOTHENATE METABOLISM | Genes involved in Vitamin B5 (pantothenate) metabolism |
0.0 | 0.1 | REACTOME FGFR LIGAND BINDING AND ACTIVATION | Genes involved in FGFR ligand binding and activation |
0.0 | 0.1 | REACTOME APOBEC3G MEDIATED RESISTANCE TO HIV1 INFECTION | Genes involved in APOBEC3G mediated resistance to HIV-1 infection |
0.0 | 0.2 | REACTOME RETROGRADE NEUROTROPHIN SIGNALLING | Genes involved in Retrograde neurotrophin signalling |
0.0 | 0.2 | REACTOME ACTIVATION OF CHAPERONE GENES BY ATF6 ALPHA | Genes involved in Activation of Chaperone Genes by ATF6-alpha |
0.0 | 2.1 | REACTOME PEPTIDE CHAIN ELONGATION | Genes involved in Peptide chain elongation |
0.0 | 0.2 | REACTOME AKT PHOSPHORYLATES TARGETS IN THE CYTOSOL | Genes involved in AKT phosphorylates targets in the cytosol |
0.0 | 0.6 | REACTOME SULFUR AMINO ACID METABOLISM | Genes involved in Sulfur amino acid metabolism |
0.0 | 0.1 | REACTOME ACYL CHAIN REMODELLING OF PE | Genes involved in Acyl chain remodelling of PE |
0.0 | 0.4 | REACTOME FANCONI ANEMIA PATHWAY | Genes involved in Fanconi Anemia pathway |
0.0 | 0.1 | REACTOME DIGESTION OF DIETARY CARBOHYDRATE | Genes involved in Digestion of dietary carbohydrate |
0.0 | 0.4 | REACTOME IL RECEPTOR SHC SIGNALING | Genes involved in Interleukin receptor SHC signaling |
0.0 | 0.3 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
0.0 | 0.1 | REACTOME P38MAPK EVENTS | Genes involved in p38MAPK events |
0.0 | 0.0 | REACTOME G ALPHA Z SIGNALLING EVENTS | Genes involved in G alpha (z) signalling events |
0.0 | 0.0 | REACTOME CREB PHOSPHORYLATION THROUGH THE ACTIVATION OF CAMKII | Genes involved in CREB phosphorylation through the activation of CaMKII |
0.0 | 0.6 | REACTOME ACTIVATION OF CHAPERONE GENES BY XBP1S | Genes involved in Activation of Chaperone Genes by XBP1(S) |
0.0 | 0.0 | REACTOME CYTOKINE SIGNALING IN IMMUNE SYSTEM | Genes involved in Cytokine Signaling in Immune system |
0.0 | 0.1 | REACTOME EARLY PHASE OF HIV LIFE CYCLE | Genes involved in Early Phase of HIV Life Cycle |
0.0 | 0.6 | REACTOME G ALPHA I SIGNALLING EVENTS | Genes involved in G alpha (i) signalling events |
0.0 | 0.1 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 2 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 2 Promoter |
0.0 | 0.3 | REACTOME ABC FAMILY PROTEINS MEDIATED TRANSPORT | Genes involved in ABC-family proteins mediated transport |